alloxan has been researched along with Hyperglycemia in 188 studies
Alloxan: Acidic compound formed by oxidation of URIC ACID. It is isolated as an efflorescent crystalline hydrate.
alloxan : A member of the class of pyrimidones, the structure of which is that of perhydropyrimidine substituted at C-2, -4, -5 and -6 by oxo groups.
Hyperglycemia: Abnormally high BLOOD GLUCOSE level.
Excerpt | Relevance | Reference |
---|---|---|
"Our experimental results indicate that taxifolin alleviates alloxan-induced hyperglycemia-related neuropathy and neuropathic pain." | 8.12 | The effects of taxifolin on neuropathy related with hyperglycemia and neuropathic pain in rats: A biochemical and histopathological evaluation. ( Alay, M; Altuner, D; Atmaca, M; Bulut, S; Coban, A; Sakin, A; Sonmez, MG; Suleyman, B; Suleyman, H; Yazici, GN, 2022) |
" Don for potential anti-diabetic activity in the in vivo mouse model of alloxan-induced hyperglycemia." | 8.12 | Detailed approach toward the anti-hyperglycemic potential of Sterculia diversifolia G. Don against alloxan-induced in vivo hyperglycemia model. ( Achyut, A; Amir, Z; Amna, N; Fazle, R; Irfan, U; Shafiq Ur, R, 2022) |
" Several experimental groups were tested: (a) animals that were subjected to long-term (42-day) alloxan-hyperglycemia and protected with insulin, (b) healthy animals that received a low dose of insulin that does not produce changes in glycemia, and (c) animals that received long-term treatment with fluoxetine." | 7.91 | Responsivity of lateral septum-mPFC connections in alloxan-induced hyperglycemia. ( Contreras, CM; Gutiérrez-García, AG; Moreno-Cortés, ML, 2019) |
" We investigated whether increases in the duration of hyperglycemia result in the development of corneal lesions in a mouse model of alloxan (AL)- or streptozotocin (STZ)-induced type 1 diabetes." | 7.88 | Extended Duration of Hyperglycemia Result in Human-Like Corneal Nerve Lesions in Mice With Alloxan- and Streptozotocin-Induced Type 1 Diabetes. ( Matsuura, T; Ozaki, K; Terayama, Y, 2018) |
"Alloxan induces oxidative stress and hyperglycemia in animal models." | 7.83 | Protective effect of vitamin E against alloxan-induced mouse hyperglycemia. ( Doi, W; Masuoka, N; Takemoto, K, 2016) |
"From this study, we conclude that quercetin ameliorates hyperglycemia and oxidative stress, by blunting free radical induced toxicity in T2DM." | 7.80 | Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice. ( Alam, MM; Meerza, D; Naseem, I, 2014) |
"The present study was designed to investigate the effect of vanadium in alloxan-induced diabetes and cataract in rats." | 7.80 | The protective effect of vanadium against diabetic cataracts in diabetic rat model. ( Gao, XC; Han, Q; Mi, SY; Shi, DJ; Sun, L; Yu, Y, 2014) |
"The effects of original Russian preparations, derivatives of 3-hydroxypyridine and succinic acid (emoxipin, reamberin, mexidol), on the cellular composition of the cerebrocortical and diencephalic structures were studied and correlations of shifts in the cellular composition with changes in the severity of hyperglycemia in rats with alloxan diabetes were analyzed." | 7.79 | Cerebroprotective effects of emoxipin, reamberin, and mexidol in alloxan diabetes. ( Miroshnichenko, IY; Rassokhina, LM; Volchegorskii, IA, 2013) |
"We studied the dynamics of lipid peroxidation-antioxidant defense system in rat model of alloxan diabetes and compared it with disorders of carbohydrate and lipid metabolism." | 7.79 | Dynamics of lipid peroxidation-antioxidant defense system during alloxan diabetes in rats. ( Miroshnichenko, IY; Rassokhina, LM; Volchegorskii, IA, 2013) |
"The present study examined the protective effects of taurine on alloxan-induced diabetic cataracts and lens damage in male New Zealand White rabbits." | 7.78 | Protective effects of taurine against alloxan-induced diabetic cataracts and refraction changes in New Zealand White rabbits. ( Chen, YC; Chen, YY; Hsu, YW; Lin, SL; Tseng, JK; Yeh, SM, 2012) |
"Our studies suggested the possibility of controlling hyperglycemia in alloxan induced diabetic mice by the stimulation of the hepatic insulin synthesis through the systemic stimulation of NO production in the hepatocytes." | 7.78 | The control of hyperglycemia in alloxan treated diabetic mice through the stimulation of hepatic insulin synthesis due to the production of nitric oxide. ( Ghosh, R; Jana, P; Sinha, AK, 2012) |
"Alloxan and oxidative stress, which have been detected in livers of laboratory animals shortly after in vivo alloxan administration, cause in vitro mitochondrial dysfunction, thus questioning alloxan diabetes as an acceptable model for type 1 diabetes, a model that cannot legitimately be used to investigate mitochondrial metabolism in a diabetic state." | 7.77 | Early hyperglycemia following alloxan administration in vivo is not associated with altered hepatic mitochondrial function: acceptable model for type 1 diabetes? ( Alvarez-Bustamante, JA; Rendon, DA, 2011) |
"The separate impacts of the chronic diabetic state and the prevailing hyperglycemia on plasma substrates and hormones, in vivo glucose turnover, and ex vivo skeletal muscle (SkM) during exercise were examined in the same six dogs before alloxan-induced diabetes (prealloxan) and after 4-5 wk of poorly controlled hyperglycemic diabetes (HGD) in the absence and presence of approximately 300-min phlorizin-induced (glycosuria mediated) normoglycemia (NGD)." | 7.73 | Prevailing hyperglycemia is critical in the regulation of glucose metabolism during exercise in poorly controlled alloxan-diabetic dogs. ( Alford, FP; Christopher, MJ; Kemp, BE; McConell, G; Rantzau, C, 2005) |
"The effect exerted by hyperglycemia on the analgesic potential of morphine was studied in female Wistar rats with the hotplate device and the formalin test." | 7.73 | Effect of hyperglycemia on the efficacy of morphine analgesia in rats. ( Ibironke, GF; Saba, OJ, 2006) |
"Ten weeks of hyperglycemia in the alloxan induced diabetic rabbit was associated with a 14% decrease in corneal oxygen uptake, a 14% decrease in corneal epithelial ouabain-insensitive ATPase activity and no change in corneal epithelial ouabain-sensitive ATPase activity." | 7.70 | Oxygen consumption and ATPase activity in the corneal epithelium of rabbits with alloxan induced hyperglycemia. ( Herse, P; Petchell, M, 1998) |
" We examined whether endogenous inhibitors of NO synthesis are involved in the augmentation of intimal hyperplasia in rabbits with hyperglycaemia induced by alloxan." | 7.70 | Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia. ( Azuma, H; Goto, M; Masuda, H; Tamaoki, S, 1999) |
" sativum) to alloxan induced diabetic (ALX-D) mice significantly lowered the serum glucose levels, nociceptive response in tail-flick, hotplate, allodynia, formalin test and relative thickness, weight of hind paw in formalin induced Paw oedema test, over 28 days, thus, showing the reversal trend in hyperglycemia and hyperalgesia compared to ALX-D mice." | 7.70 | Reduced nociceptive responses in mice with alloxan induced hyperglycemia after garlic (Allium sativum Linn.) treatment. ( Kumar, GR; Reddy, KP, 1999) |
" It did not modify the hyperglycemia induced by epinephrine (normal islet beta-cells) or alloxan (impaired islet beta-cells)." | 7.70 | Urethane-induced hyperglycemia. ( Du, ZJ; Fu, SX; Ren, LM; Wang, MY, 2000) |
" We have used this model system to investigate whether 5 to 9 weeks of alloxan-induced hyperglycemia increases platelet adhesion and aggregation on a damaged vessel wall in vivo as well as platelet aggregation in vitro." | 7.67 | Alloxan-induced hyperglycemia in rabbits and the response of platelets to aggregating agents in vitro and to exposed subendothelium in vivo. ( Ingerman-Wojenski, CM; Silver, MJ; Smith, M, 1987) |
"The effects of peripheral venous and portal venous delivery of insulin by a closed-loop insulin infusion device (Biostator GCIIS) on postprandial hyperglycemia and rates of glucose appearance, disappearance, and clearance were compared in alloxan-diabetic dogs." | 7.66 | Effect of peripheral versus portal venous administration of insulin on postprandial hyperglycemia and glucose turnover in alloxan-diabetic dogs. ( Clemens, AH; Gerich, JE; Hall, LD; Haymond, MW; Patton, GS; Rizza, RA; Service, FJ; Westland, RE, 1981) |
"In two studies for toxicity, cataracts occurred in beagle dogs given diazoxide daily in high doses." | 7.65 | Cataracts in beagle dogs given diazoxide. ( Field, WE; Schiavo, DM; Vymetal, FJ, 1975) |
"Alloxan diabetic mice were treated with EGCG." | 5.72 | (-)-Epigallocatechin gallate (EGCG) pharmacokinetics and molecular interactions towards amelioration of hyperglycemia, hyperlipidemia associated hepatorenal oxidative injury in alloxan induced diabetic mice. ( Adnan, M; Badraoui, R; Ben-Nasr, H; Chappard, D; El-Feki, A; Gargouri, M; Kausar, MA; Magné, C; Saeed, M; Siddiqui, AJ; Snoussi, M; Soussi, A, 2022) |
"Alloxan is a compound widely used in models of diabetes mellitus due to its ability for damage insulin-producing β-cells." | 5.37 | Inhibition of δ-aminolevulinate dehydratase is not closely related to the development of hyperglycemia in alloxan-induced diabetic mice. ( Barbosa, NB; Brito, VB; da Luz, SC; da Rocha, JB; de Carvalho, NR; Folmer, V; Puntel, GO, 2011) |
"Pioglitazone treatment for 8 weeks affected GSH-Px activity in diabetic liver (261." | 5.33 | Effects of pioglitazone on hyperglycemia-induced alterations in antioxidative system in tissues of alloxan-treated diabetic animals. ( Gumieniczek, A, 2005) |
"Alloxan treatment, however, does not alter lymph insulin kinetics, indicating that insulin resistance of Type 1 (insulin-dependent) diabetes mellitus reflects direct impairment at the cellular level." | 5.30 | Evidence for direct action of alloxan to induce insulin resistance at the cellular level. ( Ader, M; Bergman, RN; Richey, JM, 1998) |
"Alloxan is a diabetogenic agent which apparently acts through formation of superoxide radicals formed by redox cycling." | 5.30 | Enhanced alloxan-induced beta-cell damage and delayed recovery from hyperglycemia in mice lacking extracellular-superoxide dismutase. ( Jonsson, LM; Marklund, SL; Sentman, ML, 1999) |
"Therefore, it is inferred from the study that MFE can exert a protective effect by suppressing hyperglycemia and modulating oxidative stress and apoptosis in alloxan-administered diabetic mice." | 4.31 | Therapeutic Potential of ( Almutary, AG; Bhan, S; Bora, J; Haque, S; Hussain, A; Malik, S; Rustagi, S; Sadier, NS; Sahariah, P; Singh, N; Syiem, D, 2023) |
" Group I acted as the control, whereas groups II, III, IV, and V were considered experimental groups which received a single dosage (150 mg/kg body weight) of alloxan (ALX) intraperitoneally (i." | 4.12 | Co-administration of ( Kar, A; Panda, S; Sharma, N; Yadav, D, 2022) |
" Don for potential anti-diabetic activity in the in vivo mouse model of alloxan-induced hyperglycemia." | 4.12 | Detailed approach toward the anti-hyperglycemic potential of Sterculia diversifolia G. Don against alloxan-induced in vivo hyperglycemia model. ( Achyut, A; Amir, Z; Amna, N; Fazle, R; Irfan, U; Shafiq Ur, R, 2022) |
"Our experimental results indicate that taxifolin alleviates alloxan-induced hyperglycemia-related neuropathy and neuropathic pain." | 4.12 | The effects of taxifolin on neuropathy related with hyperglycemia and neuropathic pain in rats: A biochemical and histopathological evaluation. ( Alay, M; Altuner, D; Atmaca, M; Bulut, S; Coban, A; Sakin, A; Sonmez, MG; Suleyman, B; Suleyman, H; Yazici, GN, 2022) |
" Several experimental groups were tested: (a) animals that were subjected to long-term (42-day) alloxan-hyperglycemia and protected with insulin, (b) healthy animals that received a low dose of insulin that does not produce changes in glycemia, and (c) animals that received long-term treatment with fluoxetine." | 3.91 | Responsivity of lateral septum-mPFC connections in alloxan-induced hyperglycemia. ( Contreras, CM; Gutiérrez-García, AG; Moreno-Cortés, ML, 2019) |
" We investigated whether increases in the duration of hyperglycemia result in the development of corneal lesions in a mouse model of alloxan (AL)- or streptozotocin (STZ)-induced type 1 diabetes." | 3.88 | Extended Duration of Hyperglycemia Result in Human-Like Corneal Nerve Lesions in Mice With Alloxan- and Streptozotocin-Induced Type 1 Diabetes. ( Matsuura, T; Ozaki, K; Terayama, Y, 2018) |
" Hyperglycemia was induced by alloxan on Sprague Dawley rats." | 3.88 | Effect of Moringa oleifera consumption on diabetic rats. ( Guerrero-Quiroz, LA; López-de la Mora, DA; Nuño, K; Puebla-Mora, AG; Torres-Vitela, MR; Vázquez-Paulino, OD; Villarruel-López, A, 2018) |
"This new study aimed to evaluate for the first time the effect of Cymodocea nodosa extract (CNE) on α-amylase activity, hyperglycemia and diabetes complications in the alloxan-induced diabetic rats." | 3.85 | Effects of Cymodocea nodosa extract on metabolic disorders and oxidative stress in alloxan-diabetic rats. ( Allouche, N; Belghith, H; Belghith, K; Ben Abdallah Kolsi, R; Ben Salah, H; Chaaben, R; El Feki, A; Jamoussi, K; Jardak, N; Rebai, T, 2017) |
" Outcomes of normoglycemic studies reveals insignificant glucose lowering effects however hyperglycemic studies (glucose challenge and Alloxan inducted hyperglycemia) demonstrates significant glucose lowering effect of Aseel date especially with 300mg/kg dose." | 3.85 | Report - Antidiabetic effects of native date fruit Aseel (Phoenix dactylifera L.) in normal and hyperglycemic rats. ( Afroz, S; Ahmed, S; Jamil, S; Khan, RA, 2017) |
"Alloxan induces oxidative stress and hyperglycemia in animal models." | 3.83 | Protective effect of vitamin E against alloxan-induced mouse hyperglycemia. ( Doi, W; Masuoka, N; Takemoto, K, 2016) |
"Alloxan is an environmental food contaminant that causes DNA damage in living cells and induces hyperglycemia." | 3.83 | Nanopharmaceutical approach using pelargonidin towards enhancement of efficacy for prevention of alloxan-induced DNA damage in L6 cells via activation of PARP and p53. ( Abraham, SK; Khuda-Bukhsh, AR; Samadder, A, 2016) |
"From this study, we conclude that quercetin ameliorates hyperglycemia and oxidative stress, by blunting free radical induced toxicity in T2DM." | 3.80 | Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice. ( Alam, MM; Meerza, D; Naseem, I, 2014) |
"The present study was designed to investigate the effect of vanadium in alloxan-induced diabetes and cataract in rats." | 3.80 | The protective effect of vanadium against diabetic cataracts in diabetic rat model. ( Gao, XC; Han, Q; Mi, SY; Shi, DJ; Sun, L; Yu, Y, 2014) |
"The effects of original Russian preparations, derivatives of 3-hydroxypyridine and succinic acid (emoxipin, reamberin, mexidol), on the cellular composition of the cerebrocortical and diencephalic structures were studied and correlations of shifts in the cellular composition with changes in the severity of hyperglycemia in rats with alloxan diabetes were analyzed." | 3.79 | Cerebroprotective effects of emoxipin, reamberin, and mexidol in alloxan diabetes. ( Miroshnichenko, IY; Rassokhina, LM; Volchegorskii, IA, 2013) |
"We studied the dynamics of lipid peroxidation-antioxidant defense system in rat model of alloxan diabetes and compared it with disorders of carbohydrate and lipid metabolism." | 3.79 | Dynamics of lipid peroxidation-antioxidant defense system during alloxan diabetes in rats. ( Miroshnichenko, IY; Rassokhina, LM; Volchegorskii, IA, 2013) |
"We established that alloxan diabetes leads to early development of diabetic encephalopathy on the background of marked hyperglycemia." | 3.79 | [Dynamics of initial manifestations of experimental diabetic encephalopathy]. ( Miroshnichenko, IIu; Rassokhina, LM; Volchegorskiĭ, IA, 2013) |
"The purpose of this study was to investigate the effects of hyperglycemia on atrial interstitial fibrosis, ionic remodeling and vulnerability to atrial fibrillation (AF) in alloxan-induced diabetic rabbits." | 3.78 | Hyperglycemia aggravates atrial interstitial fibrosis, ionic remodeling and vulnerability to atrial fibrillation in diabetic rabbits. ( Cheng, L; Fu, H; Li, G; Li, J; Liu, C; Liu, T; Yang, W, 2012) |
" We injected intraperitoneally alloxan (ALX) at the dose of 200 mg/kg body weight (bw) to induce hyperglycemia in mice and tested possible hypoglycemic effects of HD in vivo by deploying two doses (100 and 200 mg/kg bw, respectively)." | 3.78 | Antihyperglycemic potentials of a threatened plant, Helonias dioica: antioxidative stress responses and the signaling cascade. ( Chakraborty, D; Dutta, S; Khuda-Bukhsh, AR; Samadder, A, 2012) |
"The present study examined the protective effects of taurine on alloxan-induced diabetic cataracts and lens damage in male New Zealand White rabbits." | 3.78 | Protective effects of taurine against alloxan-induced diabetic cataracts and refraction changes in New Zealand White rabbits. ( Chen, YC; Chen, YY; Hsu, YW; Lin, SL; Tseng, JK; Yeh, SM, 2012) |
"Our studies suggested the possibility of controlling hyperglycemia in alloxan induced diabetic mice by the stimulation of the hepatic insulin synthesis through the systemic stimulation of NO production in the hepatocytes." | 3.78 | The control of hyperglycemia in alloxan treated diabetic mice through the stimulation of hepatic insulin synthesis due to the production of nitric oxide. ( Ghosh, R; Jana, P; Sinha, AK, 2012) |
"Alloxan and oxidative stress, which have been detected in livers of laboratory animals shortly after in vivo alloxan administration, cause in vitro mitochondrial dysfunction, thus questioning alloxan diabetes as an acceptable model for type 1 diabetes, a model that cannot legitimately be used to investigate mitochondrial metabolism in a diabetic state." | 3.77 | Early hyperglycemia following alloxan administration in vivo is not associated with altered hepatic mitochondrial function: acceptable model for type 1 diabetes? ( Alvarez-Bustamante, JA; Rendon, DA, 2011) |
"This study aimed to evaluate the effect of a polysaccharide named levan, which was produced by new isolated bacteria, on oxidative stress and hyperglycemia in alloxan-induced diabetic rats." | 3.77 | Oral administration of levan polysaccharide reduces the alloxan-induced oxidative stress in rats. ( Belghith, H; Belghith, KS; Dahech, I; Feki, A; Hamden, K; Mejdoub, H, 2011) |
" These extracts were tested for their free radical (FR) scavenging potential for different FR species, hypoglycemic potential on alloxan-induced hyperglycemia, and anti-inflammatory property in carrageenan-induced paw edema and lipopolysaccharide (LPS)-induced nitric oxide (NO) production in rat peritoneal macrophage culture." | 3.77 | Chemical characterization of various fractions of leaves of Cinnamomum tamala Linn toward their antioxidant, hypoglycemic, and anti-inflammatory property. ( Chaurasia, JK; Tripathi, YB, 2011) |
"The effect exerted by hyperglycemia on the analgesic potential of morphine was studied in female Wistar rats with the hotplate device and the formalin test." | 3.73 | Effect of hyperglycemia on the efficacy of morphine analgesia in rats. ( Ibironke, GF; Saba, OJ, 2006) |
"Alloxan-induced hyperglycemia was accompanied by activation of lipid peroxidation processes with different degree of their completeness depending on the age of experimental animals." | 3.73 | Age-related differences in the degree of lipid peroxidation and state of antioxidant protection under the influence of alloxan. ( Gvozdenko, TA; Yan'kova, VI, 2005) |
"The separate impacts of the chronic diabetic state and the prevailing hyperglycemia on plasma substrates and hormones, in vivo glucose turnover, and ex vivo skeletal muscle (SkM) during exercise were examined in the same six dogs before alloxan-induced diabetes (prealloxan) and after 4-5 wk of poorly controlled hyperglycemic diabetes (HGD) in the absence and presence of approximately 300-min phlorizin-induced (glycosuria mediated) normoglycemia (NGD)." | 3.73 | Prevailing hyperglycemia is critical in the regulation of glucose metabolism during exercise in poorly controlled alloxan-diabetic dogs. ( Alford, FP; Christopher, MJ; Kemp, BE; McConell, G; Rantzau, C, 2005) |
"Tangniaole Capsule was able to decrease the blood-sugar content in normal mice and rats, heighten the level of serum insulin and the content of liver glycogen in normal rats, decrease the blood-sugar content and increase the content of liver glycogen in hyperglycemina rats induced by adrenalin, inhibit the alloxan-induced hyperglycemia of mice and rats and improve the glucose tolerance of rats." | 3.71 | [Experimental study on the hypoglycemic effect of tangniaole capsule]. ( Han, S; Sun, G; Wang, R; Wang, Y, 2002) |
"This study examined the changes in blood-brain barrier (BBB) permeability following acute aluminum (Al) exposure during acute and chronic hyperglycemia in rats." | 3.71 | Effect of aluminum on the blood-brain barrier permeability in acute and chronically hyperglycemic rats. ( Cevik, A; Elmas, I; Kalayci, RB; Kaya, M; Kücük, M, 2001) |
"To compare the effect of hyperglycemia on corneal neovascularization (NV) induced by linoleic acid hydroperoxide (LHP) in a rabbit model." | 3.71 | Lipid hydroperoxide induced corneal neovascularization in hyperglycemic rabbits. ( Arai, Y; Armstrong, D; Fukuda, S; Higa, A; Kan, K; Koide, R; Nakanishi-Ueda, T; Tsuchiya, T; Ueda, T; Watanabe, K; Yasuhara, H, 2002) |
" sativum) to alloxan induced diabetic (ALX-D) mice significantly lowered the serum glucose levels, nociceptive response in tail-flick, hotplate, allodynia, formalin test and relative thickness, weight of hind paw in formalin induced Paw oedema test, over 28 days, thus, showing the reversal trend in hyperglycemia and hyperalgesia compared to ALX-D mice." | 3.70 | Reduced nociceptive responses in mice with alloxan induced hyperglycemia after garlic (Allium sativum Linn.) treatment. ( Kumar, GR; Reddy, KP, 1999) |
"Ten weeks of hyperglycemia in the alloxan induced diabetic rabbit was associated with a 14% decrease in corneal oxygen uptake, a 14% decrease in corneal epithelial ouabain-insensitive ATPase activity and no change in corneal epithelial ouabain-sensitive ATPase activity." | 3.70 | Oxygen consumption and ATPase activity in the corneal epithelium of rabbits with alloxan induced hyperglycemia. ( Herse, P; Petchell, M, 1998) |
" We examined whether endogenous inhibitors of NO synthesis are involved in the augmentation of intimal hyperplasia in rabbits with hyperglycaemia induced by alloxan." | 3.70 | Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia. ( Azuma, H; Goto, M; Masuda, H; Tamaoki, S, 1999) |
" It did not modify the hyperglycemia induced by epinephrine (normal islet beta-cells) or alloxan (impaired islet beta-cells)." | 3.70 | Urethane-induced hyperglycemia. ( Du, ZJ; Fu, SX; Ren, LM; Wang, MY, 2000) |
" Pretreatment with PBN (150 mg/kg ip) significantly reduced the severity of hyperglycemia in both alloxan- and streptozotocin (STZ) induced diabetes." | 3.70 | Alpha-phenyl-tert-butylnitrone (PBN) inhibits NFkappaB activation offering protection against chemically induced diabetes. ( Bray, TM; Chen, G; Ho, E, 2000) |
"Insulin receptor activity and its relationship with catecholamines and serotonin were investigated in rat whole brain membranes, synaptosomes and choroid plexus in alloxan induced short term and long term hyperglycemia and hyperinsulinemia." | 3.68 | Modulation of insulin receptors and catecholamines in rat brain in hyperglycemia and hyperinsulinemia. ( Azam, M; Baquer, NZ; Gupta, G, 1990) |
" To investigate further the issue the effects of alloxan-induced hyperglycemia on the incidence and severity of haloperidol-induced perioral movements were studied in the rat." | 3.68 | Increased incidence of neuroleptic-induced perioral movements in the rat by hyperglycemia. ( Sandyk, R, 1990) |
"Inhibition of pancreatic glucagon secretion during hyperglycemia could be mediated by (a) glucose, (b) insulin, (c) somatostatin, or (d) glucose in conjunction with insulin." | 3.68 | Intra-islet insulin permits glucose to directly suppress pancreatic A cell function. ( Greenbaum, CJ; Havel, PJ; Klaff, LJ; Taborsky, GJ, 1991) |
" We have used this model system to investigate whether 5 to 9 weeks of alloxan-induced hyperglycemia increases platelet adhesion and aggregation on a damaged vessel wall in vivo as well as platelet aggregation in vitro." | 3.67 | Alloxan-induced hyperglycemia in rabbits and the response of platelets to aggregating agents in vitro and to exposed subendothelium in vivo. ( Ingerman-Wojenski, CM; Silver, MJ; Smith, M, 1987) |
"25 female sheep of the Texel breed were made hyperglycaemic by administration of alloxan monohydrate (ALX) in early pregnancy and 15 ewes served as controls." | 3.67 | Alloxan-induced diabetes mellitus in pregnant sheep and chronic fetal catheterization. ( Eskes, TK; Jongsma, HW; Lips, JP, 1988) |
"ICRF-187, (+)-1,2-bis(3,5-dioxopiperazine-1-yl)propane, has been shown to protect against alloxan diabetes (el-Hage et al." | 3.67 | Mechanism of the protective activity of ICRF-187 against alloxan-induced diabetes in mice. ( Crouch, RK; el-Hage, A; Ferrans, VJ; Herman, EH; Yang, GC, 1986) |
"The ability of NiCl2 to prevent alloxan- and streptozotocin-induced hyperglycemia was tested in rats." | 3.67 | Nickel chloride protection against alloxan- and streptozotocin-induced diabetes. ( Novelli, EL; Ribas, BO; Rodrigues, NL, 1988) |
"Hyperglycemia was induced in BALB/c mice with either streptozocin or alloxan to evaluate the effects of these drugs on primary lymphoidal tissues." | 3.67 | Definition of streptozocin toxicity for primary lymphoidal tissues. ( Wellhausen, SR, 1986) |
"The effects of peripheral venous and portal venous delivery of insulin by a closed-loop insulin infusion device (Biostator GCIIS) on postprandial hyperglycemia and rates of glucose appearance, disappearance, and clearance were compared in alloxan-diabetic dogs." | 3.66 | Effect of peripheral versus portal venous administration of insulin on postprandial hyperglycemia and glucose turnover in alloxan-diabetic dogs. ( Clemens, AH; Gerich, JE; Hall, LD; Haymond, MW; Patton, GS; Rizza, RA; Service, FJ; Westland, RE, 1981) |
"In two studies for toxicity, cataracts occurred in beagle dogs given diazoxide daily in high doses." | 3.65 | Cataracts in beagle dogs given diazoxide. ( Field, WE; Schiavo, DM; Vymetal, FJ, 1975) |
"Alloxan diabetic mice were treated with EGCG." | 1.72 | (-)-Epigallocatechin gallate (EGCG) pharmacokinetics and molecular interactions towards amelioration of hyperglycemia, hyperlipidemia associated hepatorenal oxidative injury in alloxan induced diabetic mice. ( Adnan, M; Badraoui, R; Ben-Nasr, H; Chappard, D; El-Feki, A; Gargouri, M; Kausar, MA; Magné, C; Saeed, M; Siddiqui, AJ; Snoussi, M; Soussi, A, 2022) |
"Anxiety, fear, and anhedonia are mediated by interactions between different deep structures of the temporal lobe (e." | 1.43 | Widespread blunting of hypothalamic and amygdala-septal activity and behavior in rats with long-term hyperglycemia. ( Contreras, CM; Guillén-Ruiz, G; Gutiérrez-García, AG; Moreno-Cortés, ML; Romo-González, T, 2016) |
"Diosmin treatment produces significant reduction in the blood glucose and plasma insulin level and increases the body weight when compared with diabetic rats." | 1.43 | Diosmin Modulates the NF-kB Signal Transduction Pathways and Downregulation of Various Oxidative Stress Markers in Alloxan-Induced Diabetic Nephropathy. ( Ahmed, A; Ahmed, S; Bolshette, N; Borgohain, M; Chowdhury, L; Kwatra, M; Lahkar, M; Mundhe, N, 2016) |
"In conclusion, chronic liraglutide treatment improves hyperglycemia by ameliorating beta cell mass and function in alloxan-induced diabetic mice." | 1.42 | Liraglutide improves pancreatic Beta cell mass and function in alloxan-induced diabetic mice. ( Iemoto, K; Kudo, M; Minami, K; Seino, S; Takahashi, H; Tamura, K, 2015) |
"Hyperglycemia is the primary cause of the majority of diabetes complications, including diabetic retinopathy (DR)." | 1.40 | Identification of O-GlcNAc modification targets in mouse retinal pericytes: implication of p53 in pathogenesis of diabetic retinopathy. ( Gurel, Z; Pratt, MR; Sheibani, N; Zaro, BW, 2014) |
"Alloxan was then intraperitoneally administered, and blood glucose, glucose tolerance and the insulin level in mouse blood were examined." | 1.39 | Effect of vitamin E on alloxan-induced mouse diabetes. ( Doi, W; Ishihara, K; Kamimura, W; Masuoka, N; Oda, S; Sugiyama, H; Takemoto, K; Wang, DH, 2013) |
"Hyperglycemia is independently related with excessive morbidity and mortality in cardiovascular disorders." | 1.38 | L-Arginine ameliorates cardiac left ventricular oxidative stress by upregulating eNOS and Nrf2 target genes in alloxan-induced hyperglycemic rats. ( Kumar, PH; Murugan, PS; Puhari, SS; Ramprasath, T; Selvam, GS; Vasudevan, V, 2012) |
"Alloxan-treated dogs (D; n=7) were maintained normoglycemic using 24-h/d IV insulin replacement." | 1.38 | Chronic intrarenal insulin replacement reverses diabetes mellitus-induced natriuresis and diuresis. ( Brands, MW; Duggan, AD; Manhiani, MM; Wilson, H, 2012) |
"Alloxan is a compound widely used in models of diabetes mellitus due to its ability for damage insulin-producing β-cells." | 1.37 | Inhibition of δ-aminolevulinate dehydratase is not closely related to the development of hyperglycemia in alloxan-induced diabetic mice. ( Barbosa, NB; Brito, VB; da Luz, SC; da Rocha, JB; de Carvalho, NR; Folmer, V; Puntel, GO, 2011) |
"Treatment with telmisartan may prevent the onset of alloxan-induced diabetes even under acatalasemic conditions." | 1.36 | Sensitization to alloxan-induced diabetes and pancreatic cell apoptosis in acatalasemic mice. ( Fukuoka, N; Inoue, T; Kikumoto, Y; Kitagawa, M; Maeshima, Y; Makino, H; Masuoka, N; Morinaga, H; Ogino, K; Saeki, M; Sugiyama, H; Takiue, K; Wang, DH, 2010) |
" comatus is less toxic to mice than vanadium (V)." | 1.35 | Comparison of hypoglycemic activity and toxicity of vanadium (IV) and vanadium (V) absorbed in fermented mushroom of Coprinus comatus. ( Fu, Q; Ma, Z, 2009) |
" Pharmacokinetic and pharmacodynamic parameters were examined in the interval of 30 to 180 min after p." | 1.34 | Gliclazide: pharmacokinetic-pharmacodynamic relationships in rats. ( Kvetina, J; Pastera, J; Polásková, A; Prazáková, M; Stetinová, V, 2007) |
"Pioglitazone treatment for 8 weeks affected GSH-Px activity in diabetic liver (261." | 1.33 | Effects of pioglitazone on hyperglycemia-induced alterations in antioxidative system in tissues of alloxan-treated diabetic animals. ( Gumieniczek, A, 2005) |
"Stress hyperglycemia is frequent in critically ill patients." | 1.32 | Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. ( Coopmans, W; Giulietti, AP; Mathieu, C; Michalaki, M; Van den Berghe, G; Van Herck, E; Weekers, F, 2003) |
" The aqueous extract of Syzygium alternifolium at a dosage of 0." | 1.31 | Hypoglycemic and antihyperglycemic activity of Syzygium alternifolium (Wt.) Walp. seed extracts in normal and diabetic rats. ( Rao, BK; Rao, CH, 2001) |
"Alloxan is a diabetogenic agent which apparently acts through formation of superoxide radicals formed by redox cycling." | 1.30 | Enhanced alloxan-induced beta-cell damage and delayed recovery from hyperglycemia in mice lacking extracellular-superoxide dismutase. ( Jonsson, LM; Marklund, SL; Sentman, ML, 1999) |
"Alloxan treatment, however, does not alter lymph insulin kinetics, indicating that insulin resistance of Type 1 (insulin-dependent) diabetes mellitus reflects direct impairment at the cellular level." | 1.30 | Evidence for direct action of alloxan to induce insulin resistance at the cellular level. ( Ader, M; Bergman, RN; Richey, JM, 1998) |
" Our study was designed to explore dosage schedules which might improve rabbit responsiveness to and survival after alloxan treatment." | 1.27 | Variations of susceptibility to alloxan induced diabetes in the rabbit. ( Beyer, MM; Brown, CD; Friedman, EA; Watschinger, B; Zhao, ZH, 1987) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 58 (30.85) | 18.7374 |
1990's | 20 (10.64) | 18.2507 |
2000's | 32 (17.02) | 29.6817 |
2010's | 66 (35.11) | 24.3611 |
2020's | 12 (6.38) | 2.80 |
Authors | Studies |
---|---|
Arif, B | 1 |
Arif, Z | 1 |
Ahmad, J | 1 |
Perveen, K | 1 |
Bukhari, NA | 1 |
Ashraf, JM | 1 |
Alam, K | 1 |
Alay, M | 1 |
Sonmez, MG | 1 |
Sakin, A | 1 |
Atmaca, M | 1 |
Suleyman, H | 2 |
Yazici, GN | 1 |
Coban, A | 1 |
Suleyman, B | 1 |
Bulut, S | 1 |
Altuner, D | 1 |
Awan, AM | 1 |
Majeed, W | 3 |
Muhammad, F | 1 |
Faisal, MN | 1 |
Fazle, R | 1 |
Amir, Z | 1 |
Amna, N | 2 |
Achyut, A | 1 |
Irfan, U | 1 |
Shafiq Ur, R | 1 |
Soussi, A | 1 |
Gargouri, M | 2 |
Magné, C | 2 |
Ben-Nasr, H | 1 |
Kausar, MA | 1 |
Siddiqui, AJ | 1 |
Saeed, M | 1 |
Snoussi, M | 1 |
Adnan, M | 1 |
El-Feki, A | 1 |
Chappard, D | 1 |
Badraoui, R | 1 |
Sharma, N | 1 |
Kar, A | 1 |
Panda, S | 1 |
Yadav, D | 1 |
Kabach, I | 1 |
Bouchmaa, N | 1 |
Zouaoui, Z | 1 |
Ennoury, A | 1 |
El Asri, S | 1 |
Laabar, A | 1 |
Oumeslakht, L | 1 |
Cacciola, F | 1 |
El Majdoub, YO | 1 |
Mondello, L | 1 |
Zyad, A | 1 |
Nhiri, N | 1 |
Nhiri, M | 1 |
Ben Mrid, R | 1 |
Sahariah, P | 1 |
Bora, J | 1 |
Malik, S | 1 |
Syiem, D | 1 |
Bhan, S | 1 |
Hussain, A | 1 |
Sadier, NS | 1 |
Rustagi, S | 1 |
Haque, S | 1 |
Singh, N | 1 |
Almutary, AG | 1 |
Umar, U | 1 |
Ahmed, S | 3 |
Iftikhar, A | 2 |
Iftikhar, M | 2 |
Liaqat, A | 1 |
Shahzad, S | 1 |
Abbas, M | 1 |
Mehmood, T | 1 |
Anwar, F | 1 |
Aslam, B | 1 |
Batool, M | 1 |
Zahoor, B | 1 |
Gohar, H | 1 |
Latif, I | 1 |
Zaib, M | 1 |
Sharif, A | 1 |
Akhtar, B | 1 |
Khan, HM | 1 |
Akhtar, MF | 1 |
Hassan, W | 1 |
Razzaq, F | 1 |
Nawaz, S | 1 |
Qaisar, N | 1 |
Oršolić, N | 1 |
Sirovina, D | 1 |
Odeh, D | 1 |
Gajski, G | 1 |
Balta, V | 1 |
Šver, L | 1 |
Jazvinšćak Jembrek, M | 1 |
Ezejiofor, AN | 1 |
Igweze, ZN | 1 |
Udowelle, NA | 1 |
Orisakwe, OE | 1 |
Ilić, V | 1 |
Vukmirović, S | 1 |
Stilinović, N | 1 |
Čapo, I | 1 |
Arsenović, M | 1 |
Milijašević, B | 1 |
Baldissera, MD | 1 |
Souza, CF | 1 |
Grando, TH | 1 |
Cossetin, LF | 1 |
Sagrillo, MR | 1 |
Nascimento, K | 1 |
da Silva, AS | 1 |
Machado, AK | 1 |
da Cruz, IBM | 1 |
Stefani, LM | 1 |
Klein, B | 1 |
Wagner, R | 1 |
Monteiro, SG | 1 |
Júnior, IIDS | 1 |
Barbosa, HM | 1 |
Carvalho, DCR | 1 |
Barros, RA | 1 |
Albuquerque, FP | 1 |
da Silva, DHA | 1 |
Souza, GR | 1 |
Souza, NAC | 1 |
Rolim, LA | 1 |
Silva, FMM | 1 |
Duarte, GIBP | 1 |
Almeida, JRGDS | 1 |
de Oliveira Júnior, FM | 1 |
Gomes, DA | 1 |
Lira, EC | 1 |
Dar, PA | 1 |
Ali, F | 1 |
Sheikh, IA | 1 |
Ganie, SA | 1 |
Dar, TA | 1 |
Bharti, V | 1 |
Mehta, A | 1 |
Mourya, GK | 1 |
Ahirwal, L | 1 |
Bajpai, VK | 1 |
Shukla, S | 1 |
Wu, CY | 1 |
Wang, H | 1 |
He, XX | 1 |
Wu, DW | 1 |
Yue, W | 1 |
Wu, QN | 1 |
Khan, RA | 1 |
Jamil, S | 1 |
Afroz, S | 1 |
Tanko, Y | 1 |
Salisu, AI | 1 |
Mohammed, KA | 1 |
Musa, SA | 1 |
Jimoh, A | 1 |
Yusuf, R | 1 |
Attia, ES | 1 |
Amer, AH | 1 |
Hasanein, MA | 1 |
Xiao, X | 1 |
Guo, P | 1 |
Shiota, C | 1 |
Zhang, T | 1 |
Coudriet, GM | 1 |
Fischbach, S | 1 |
Prasadan, K | 1 |
Fusco, J | 1 |
Ramachandran, S | 1 |
Witkowski, P | 1 |
Piganelli, JD | 1 |
Gittes, GK | 1 |
Villarruel-López, A | 1 |
López-de la Mora, DA | 1 |
Vázquez-Paulino, OD | 1 |
Puebla-Mora, AG | 1 |
Torres-Vitela, MR | 1 |
Guerrero-Quiroz, LA | 1 |
Nuño, K | 1 |
Abdullah, KM | 1 |
Alam, MM | 2 |
Iqbal, Z | 1 |
Naseem, I | 2 |
Ibrahim, FA | 1 |
Usman, LA | 1 |
Akolade, JO | 1 |
Idowu, OA | 1 |
Abdulazeez, AT | 1 |
Amuzat, AO | 1 |
Ozaki, K | 1 |
Terayama, Y | 1 |
Matsuura, T | 1 |
Bhattacharya, S | 1 |
Maji, U | 1 |
Khan, GA | 1 |
Das, R | 1 |
Sinha, AK | 2 |
Ghosh, C | 1 |
Maiti, S | 1 |
Miranda Pedroso, TF | 1 |
Bonamigo, TR | 1 |
da Silva, J | 1 |
Vasconcelos, P | 1 |
Félix, JM | 1 |
Cardoso, CAL | 1 |
Souza, RIC | 1 |
Dos Santos, AC | 1 |
Volobuff, CRF | 1 |
Formagio, ASN | 1 |
Trichez, VDK | 1 |
Contreras, CM | 2 |
Gutiérrez-García, AG | 2 |
Moreno-Cortés, ML | 2 |
Kamimura, W | 1 |
Doi, W | 2 |
Takemoto, K | 2 |
Ishihara, K | 1 |
Wang, DH | 2 |
Sugiyama, H | 2 |
Oda, S | 1 |
Masuoka, N | 3 |
Volchegorskii, IA | 5 |
Rassokhina, LM | 5 |
Miroshnichenko, IY | 2 |
Miroshnichenko, IIu | 3 |
Sebai, H | 1 |
Selmi, S | 1 |
Rtibi, K | 1 |
Souli, A | 1 |
Gharbi, N | 1 |
Sakly, M | 1 |
Sun, L | 1 |
Shi, DJ | 1 |
Gao, XC | 1 |
Mi, SY | 1 |
Yu, Y | 1 |
Han, Q | 1 |
El-Tantawy, WH | 1 |
Haleem, EN | 1 |
Malkin, MP | 1 |
Maĭzyllin, RM | 1 |
Priakhina, KE | 1 |
Kalugina, AV | 1 |
Omeh, YN | 1 |
Onoja, SO | 1 |
Ezeja, MI | 1 |
Okwor, PO | 1 |
Gurel, Z | 1 |
Zaro, BW | 1 |
Pratt, MR | 1 |
Sheibani, N | 1 |
Meerza, D | 1 |
Langoni Cassettari, L | 1 |
Colli Rocha Dias, P | 1 |
Natália Lucchesi, A | 1 |
Ferraz de Arruda, M | 1 |
Veruska Paiva Ortolan, E | 1 |
Marques, ME | 1 |
Spadella, CT | 2 |
Pinto, IF | 1 |
Silva, RP | 1 |
Chaves Filho, Ade B | 1 |
Dantas, LS | 1 |
Bispo, VS | 1 |
Matos, IA | 1 |
Otsuka, FA | 1 |
Santos, AC | 1 |
Matos, HR | 1 |
Zhiliuk, VI | 1 |
Mamchur, VI | 1 |
Pavlov, SV | 1 |
Tamura, K | 1 |
Minami, K | 1 |
Kudo, M | 1 |
Iemoto, K | 1 |
Takahashi, H | 1 |
Seino, S | 1 |
Ma, L | 1 |
Zhang, S | 1 |
Du, M | 1 |
Fraga-Silva, TF | 1 |
Marchetti, CM | 1 |
Mimura, LA | 1 |
Locachevic, GA | 1 |
Golim, MA | 1 |
Venturini, J | 1 |
Arruda, MS | 1 |
Samadder, A | 2 |
Abraham, SK | 1 |
Khuda-Bukhsh, AR | 2 |
Guillén-Ruiz, G | 1 |
Romo-González, T | 1 |
Lemper, M | 1 |
De Groef, S | 1 |
Stangé, G | 1 |
Baeyens, L | 1 |
Heimberg, H | 1 |
Mundhe, N | 1 |
Borgohain, M | 1 |
Chowdhury, L | 1 |
Kwatra, M | 1 |
Bolshette, N | 1 |
Ahmed, A | 1 |
Lahkar, M | 1 |
Kitamura, KI | 1 |
Andoh, T | 1 |
Okesaku, W | 1 |
Tazaki, Y | 1 |
Ogai, K | 1 |
Sugitani, K | 1 |
Kobayashi, I | 1 |
Suzuki, N | 1 |
Chen, W | 1 |
Ikegame, M | 1 |
Hattori, A | 1 |
Ramu, R | 1 |
Shirahatti, PS | 1 |
Nayakavadi, S | 1 |
R, V | 1 |
Zameer, F | 1 |
Dhananjaya, BL | 1 |
Prasad Mn, N | 1 |
El Feki, A | 2 |
Ben Abdallah Kolsi, R | 1 |
Ben Salah, H | 1 |
Jardak, N | 1 |
Chaaben, R | 1 |
Rebai, T | 1 |
Jamoussi, K | 1 |
Allouche, N | 1 |
Belghith, H | 2 |
Belghith, K | 1 |
Kang, ES | 1 |
Han, D | 1 |
Park, J | 1 |
Kwak, TK | 1 |
Oh, MA | 1 |
Lee, SA | 1 |
Choi, S | 1 |
Park, ZY | 1 |
Kim, Y | 1 |
Lee, JW | 1 |
Han, C | 2 |
Liu, T | 2 |
LAYTON, A | 1 |
OLMSTED, JM | 1 |
BUNTING, H | 1 |
Cazarolli, LH | 1 |
Folador, P | 1 |
Moresco, HH | 1 |
Brighente, IM | 1 |
Pizzolatti, MG | 1 |
Silva, FR | 1 |
Ma, Z | 1 |
Fu, Q | 1 |
Liu, SX | 1 |
Fu, ZP | 1 |
Mu, RM | 1 |
Hu, ZB | 1 |
Wang, FJ | 1 |
Wang, XR | 1 |
Curtis, GW | 1 |
Robbins, SL | 1 |
Glickman, I | 1 |
Kikumoto, Y | 1 |
Inoue, T | 1 |
Morinaga, H | 1 |
Takiue, K | 1 |
Kitagawa, M | 1 |
Fukuoka, N | 1 |
Saeki, M | 1 |
Maeshima, Y | 1 |
Ogino, K | 1 |
Makino, H | 1 |
Albayrak, A | 1 |
Uyanik, MH | 1 |
Odabasoglu, F | 1 |
Halici, Z | 1 |
Uyanik, A | 1 |
Bayir, Y | 1 |
Albayrak, F | 1 |
Albayrak, Y | 1 |
Polat, B | 1 |
Brito, VB | 1 |
da Rocha, JB | 1 |
Puntel, GO | 1 |
da Luz, SC | 1 |
Barbosa, NB | 1 |
de Carvalho, NR | 1 |
Folmer, V | 1 |
Dallak, MA | 1 |
Bin-Jaliah, I | 1 |
Al-Khateeb, MA | 1 |
Nwoye, LO | 1 |
Shatoor, AS | 1 |
Soliman, HS | 1 |
Al-Hashem, FH | 1 |
KASS, EH | 1 |
WAISBREN, BA | 1 |
Chaurasia, JK | 1 |
Tripathi, YB | 1 |
Gumieniczek, A | 2 |
Komsta, L | 1 |
Chehab, MR | 1 |
Cekic, V | 1 |
Vasovic, V | 1 |
Jakovljevic, V | 1 |
Mikov, M | 1 |
Sabo, A | 1 |
Rendon, DA | 1 |
Alvarez-Bustamante, JA | 1 |
King, JL | 1 |
Mason, JO | 1 |
Cartner, SC | 1 |
Guidry, C | 1 |
Dahech, I | 1 |
Belghith, KS | 1 |
Hamden, K | 1 |
Feki, A | 1 |
Mejdoub, H | 1 |
Chakraborty, D | 1 |
Dutta, S | 1 |
Manhiani, MM | 1 |
Duggan, AD | 1 |
Wilson, H | 1 |
Brands, MW | 1 |
Soares de Moura, R | 1 |
da Costa, GF | 1 |
Moreira, AS | 1 |
Queiroz, EF | 1 |
Moreira, DD | 1 |
Garcia-Souza, EP | 1 |
Resende, AC | 1 |
Moura, AS | 1 |
Teixeira, MT | 1 |
Ghosh, R | 1 |
Jana, P | 1 |
Thieme, R | 1 |
Schindler, M | 1 |
Ramin, N | 1 |
Fischer, S | 1 |
Mühleck, B | 1 |
Fischer, B | 1 |
Navarrete Santos, A | 1 |
Fang, Y | 1 |
Wang, LP | 1 |
Du, FL | 1 |
Liu, WJ | 1 |
Ren, GL | 1 |
Liu, C | 1 |
Fu, H | 1 |
Li, J | 1 |
Yang, W | 1 |
Cheng, L | 1 |
Li, G | 1 |
Hsu, YW | 1 |
Yeh, SM | 1 |
Chen, YY | 1 |
Chen, YC | 1 |
Lin, SL | 1 |
Tseng, JK | 1 |
Ramprasath, T | 1 |
Kumar, PH | 1 |
Puhari, SS | 1 |
Murugan, PS | 1 |
Vasudevan, V | 1 |
Selvam, GS | 1 |
Lucchesi, AN | 1 |
Alberti, S | 1 |
Resende, LA | 1 |
Stetinová, V | 2 |
Smetanová, L | 1 |
Grossmann, V | 1 |
Anzenbacher, P | 1 |
Hosseinzadeh, H | 1 |
Ramezani, M | 1 |
Danaei, AR | 1 |
Wang, BX | 1 |
Zhou, QL | 1 |
Yang, M | 1 |
Wang, Y | 3 |
Cui, ZY | 1 |
Liu, YQ | 1 |
Ikejima, T | 1 |
Higa, A | 1 |
Nakanishi-Ueda, T | 1 |
Arai, Y | 1 |
Tsuchiya, T | 1 |
Ueda, T | 1 |
Fukuda, S | 1 |
Watanabe, K | 1 |
Kan, K | 1 |
Yasuhara, H | 1 |
Koide, R | 1 |
Armstrong, D | 1 |
Han, S | 1 |
Sun, G | 1 |
Wang, R | 1 |
Guillonneau, C | 1 |
Charton, Y | 1 |
Ginot, YM | 1 |
Fouquier-d'Hérouël, MV | 1 |
Bertrand, M | 1 |
Lockhart, B | 2 |
Lestage, P | 2 |
Goldstein, S | 1 |
Venkatesh, S | 1 |
Reddy, GD | 1 |
Reddy, BM | 1 |
Ramesh, M | 1 |
Rao, AV | 1 |
Zhang, HN | 1 |
He, JH | 1 |
Yuan, L | 1 |
Lin, ZB | 1 |
Weekers, F | 1 |
Giulietti, AP | 1 |
Michalaki, M | 1 |
Coopmans, W | 1 |
Van Herck, E | 1 |
Mathieu, C | 1 |
Van den Berghe, G | 1 |
OSMAN SAKA, M | 1 |
BENARD, H | 1 |
CRUZ-HORN, A | 1 |
GALISTIN, P | 1 |
RAMBERT, P | 1 |
SEEMAN, A | 1 |
KOSAKA, K | 2 |
MAZUMDER, R | 1 |
BANERJEE, S | 1 |
SOLOMON, J | 1 |
MAYER, J | 2 |
KUFTINEC, DM | 1 |
ARNOVLJEVITCH, V | 3 |
CHAHOVITCH, X | 3 |
MILOSAVLJEVITCH, V | 3 |
ANAF, M | 1 |
PAGNI, G | 1 |
HOET, JJ | 1 |
Zhang, R | 1 |
Zhou, J | 1 |
Jia, Z | 1 |
Zhang, Y | 1 |
Gu, G | 1 |
SILIPRANDI, N | 1 |
BASSI, E | 1 |
Sanders, NM | 1 |
Dunn-Meynell, AA | 1 |
Levin, BE | 1 |
Ananthi, J | 1 |
Prakasam, A | 1 |
Pugalendi, KV | 1 |
Christopher, MJ | 1 |
Rantzau, C | 1 |
McConell, G | 1 |
Kemp, BE | 1 |
Alford, FP | 1 |
Ramakrishnan, R | 1 |
Prabhakaran, K | 1 |
Jayakumar, AR | 1 |
Gunasekaran, P | 1 |
Sheeladevi, R | 1 |
Suthanthirarajan, N | 1 |
Yan'kova, VI | 1 |
Gvozdenko, TA | 1 |
Dhanabal, SP | 1 |
Sureshkumar, M | 1 |
Ramanathan, M | 1 |
Suresh, B | 1 |
Kothai, R | 1 |
Arul, B | 1 |
Kumar, KS | 1 |
Christina, AJ | 1 |
Yuan, J | 1 |
Li, L | 1 |
Kvetina, J | 1 |
Pastera, J | 1 |
Polásková, A | 1 |
Prazáková, M | 1 |
Ibironke, GF | 1 |
Saba, OJ | 1 |
MOLANDER, DW | 1 |
KIRSCHBAUM, A | 1 |
Gulbenkian, A | 1 |
Grasso, AY | 1 |
Tabachnick, II | 1 |
Håkanson, R | 1 |
Lundquist, I | 1 |
Rerup, C | 1 |
Farrell, PM | 1 |
Engle, MJ | 1 |
Frantz, ID | 1 |
Goldman, AS | 1 |
Kalkhoff, R | 1 |
Kemnitz, JW | 1 |
Perelman, R | 1 |
Stern, JS | 1 |
Susa, JB | 1 |
Sandler, S | 1 |
Andersson, A | 2 |
Eriksson, UJ | 1 |
YoungLai, EV | 1 |
Boquist, L | 1 |
Bäckman, AM | 1 |
Strömberg, C | 1 |
Rizza, RA | 1 |
Westland, RE | 1 |
Hall, LD | 1 |
Patton, GS | 1 |
Haymond, MW | 1 |
Clemens, AH | 1 |
Gerich, JE | 1 |
Service, FJ | 1 |
Perez, G | 1 |
Kemmer, FW | 1 |
Lickley, HL | 1 |
Vranic, M | 1 |
Vasilenko, P | 1 |
Adams, WC | 1 |
Frieden, EH | 1 |
Bulakh, PM | 1 |
Chandorkar, AG | 1 |
Balsara, JJ | 1 |
Ranade, SM | 1 |
Albal, MV | 1 |
Siddiqui, MA | 1 |
Rahman, MA | 1 |
Ahrén, B | 1 |
Sundkvist, G | 1 |
Jansson, L | 1 |
Eizirik, DL | 1 |
Pipeleers, DG | 1 |
Borg, LA | 1 |
Hellerström, C | 2 |
Kern, TS | 1 |
Engerman, RL | 1 |
Soto, C | 1 |
Muriel, P | 1 |
Reyes, JL | 1 |
Kodama, T | 1 |
Iwase, M | 1 |
Nunoi, K | 1 |
Maki, Y | 1 |
Yoshinari, M | 1 |
Fujishima, M | 1 |
Wang, PY | 1 |
Yeğen, E | 1 |
Akçay, F | 1 |
Yiğitoğlu, MR | 1 |
Celik, I | 1 |
Suzek, H | 1 |
Odabaşioğlu, F | 1 |
Stefek, M | 1 |
Trnkova, Z | 1 |
Herse, P | 1 |
Petchell, M | 1 |
Ader, M | 1 |
Richey, JM | 1 |
Bergman, RN | 1 |
Masuda, H | 1 |
Goto, M | 1 |
Tamaoki, S | 1 |
Azuma, H | 1 |
Erenmemisoglu, A | 1 |
Ozdogan, UK | 1 |
Saraymen, R | 1 |
Tutus, A | 1 |
Sentman, ML | 1 |
Jonsson, LM | 1 |
Marklund, SL | 1 |
Kumar, GR | 1 |
Reddy, KP | 1 |
Ho, E | 2 |
Chen, G | 1 |
Bray, TM | 1 |
Bonhomme, N | 1 |
Roger, A | 1 |
Dorey, G | 1 |
Casara, P | 1 |
Rao, BK | 1 |
Rao, CH | 1 |
Wang, MY | 1 |
Ren, LM | 1 |
Du, ZJ | 1 |
Fu, SX | 1 |
Quan, N | 1 |
La, W | 1 |
Tsai, YH | 1 |
Bray, T | 1 |
Kücük, M | 1 |
Kalayci, RB | 1 |
Cevik, A | 1 |
Elmas, I | 1 |
Kaya, M | 1 |
Park, BH | 1 |
Park, JW | 1 |
Purri, P | 1 |
Pastore, V | 1 |
Masciariello, S | 1 |
Zotti, GC | 1 |
Tajana, G | 1 |
Soscia, A | 1 |
Di Concilio, R | 1 |
Belli, F | 1 |
Honour, AJ | 1 |
Hockaday, TD | 1 |
Ghafghazi, T | 1 |
Sheriat, HS | 1 |
Dastmalchi, T | 1 |
Barnett, RC | 1 |
Kimura, H | 1 |
Kuriyama, K | 1 |
Schiavo, DM | 1 |
Field, WE | 1 |
Vymetal, FJ | 1 |
Edwardson, JM | 1 |
Dean, PM | 1 |
Greenbaum, CJ | 1 |
Havel, PJ | 1 |
Taborsky, GJ | 1 |
Klaff, LJ | 1 |
Schröder, S | 1 |
Palinski, W | 1 |
Schmid-Schönbein, GW | 1 |
Bhattacharya, SK | 1 |
Saraswati, M | 1 |
Sandyk, R | 1 |
Azam, M | 1 |
Gupta, G | 1 |
Baquer, NZ | 1 |
Wellhausen, SR | 1 |
Novelli, EL | 1 |
Rodrigues, NL | 1 |
Ribas, BO | 1 |
el-Hage, A | 1 |
Herman, EH | 1 |
Yang, GC | 1 |
Crouch, RK | 1 |
Ferrans, VJ | 1 |
Lips, JP | 1 |
Jongsma, HW | 1 |
Eskes, TK | 1 |
Zhao, ZH | 1 |
Watschinger, B | 1 |
Brown, CD | 1 |
Beyer, MM | 1 |
Friedman, EA | 1 |
Ingerman-Wojenski, CM | 1 |
Smith, M | 1 |
Silver, MJ | 1 |
Hsu, C | 1 |
Hsu, HK | 1 |
Lee, JN | 1 |
Yu, JY | 1 |
Brookshire, KH | 1 |
Yasumitsu, C | 1 |
Matsuoka, Y | 1 |
Tanaka, I | 1 |
Gunnarsson, R | 1 |
Rose, H | 1 |
Esposito-Avella, M | 1 |
Mennear, JH | 1 |
Havu, N | 1 |
Chavin, W | 1 |
Young, JE | 1 |
Biuw, LW | 1 |
Ratsimamanga, AR | 1 |
Chirvan-Nia, P | 1 |
Bibal-Prot, P | 1 |
Bristol, J | 1 |
Harley, J | 1 |
Gallicchio, V | 1 |
Yoshida, T | 1 |
Otaka, T | 1 |
Uchiyama, M | 1 |
Ogawa, S | 1 |
Townley, RG | 1 |
Daley, D | 1 |
Selenke, W | 1 |
Wellmann, KF | 1 |
Volk, BW | 1 |
Lazarus, SS | 1 |
Gospodinow, C | 1 |
Galabowa, R | 1 |
Petkov, P | 1 |
Cenedella, RJ | 1 |
Saxe, LH | 1 |
Morgan, CR | 1 |
Wiesman, HJ | 1 |
Masada, A | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Impact of Bariatric Surgery on Circulating Inflammatory and Pro-vascular Progenitor Cell Populations.[NCT04132531] | 38 participants (Actual) | Observational | 2018-05-01 | Completed | |||
Determining the Factors That Affects Emergency Department Visits of Hyperglycemic Patients in 30 Days.[NCT04665128] | 120 participants (Anticipated) | Observational | 2020-12-15 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for alloxan and Hyperglycemia
Article | Year |
---|---|
Congenital malformations in diabetic animal models--a review.
Topics: Alloxan; Animals; Chromosome Aberrations; Congenital Abnormalities; Copper; Cricetinae; Diabetes Mel | 1984 |
187 other studies available for alloxan and Hyperglycemia
Article | Year |
---|---|
Attenuation of hyperglycemia and amadori products by aminoguanidine in alloxan-diabetic rabbits occurs via enhancement in antioxidant defenses and control of stress.
Topics: Alloxan; Animals; Antioxidants; Case-Control Studies; Catalase; Diabetes Mellitus, Experimental; Dia | 2022 |
The effects of taxifolin on neuropathy related with hyperglycemia and neuropathic pain in rats: A biochemical and histopathological evaluation.
Topics: Alloxan; Animals; Antioxidants; Hyperglycemia; Male; Neuralgia; Oxidative Stress; Quercetin; Rats; R | 2022 |
Acacia jacquemontii ethyl acetate extract reduces hyperglycemia and pro-inflammatory markers while increasing endogenous antioxidant potential in alloxan-induced diabetic rats.
Topics: Acacia; Alloxan; alpha-Amylases; Animals; Antioxidants; Blood Glucose; Catalase; Diabetes Mellitus, | 2022 |
Detailed approach toward the anti-hyperglycemic potential of Sterculia diversifolia G. Don against alloxan-induced in vivo hyperglycemia model.
Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Humans; Hyperglycemia; Hypoglycemi | 2022 |
(-)-Epigallocatechin gallate (EGCG) pharmacokinetics and molecular interactions towards amelioration of hyperglycemia, hyperlipidemia associated hepatorenal oxidative injury in alloxan induced diabetic mice.
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Catechin; Diabetes Mellitus, Experimental; Hyperglyce | 2022 |
Co-administration of
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Glucose | 2022 |
Phytochemical profile and antioxidant capacity, α-amylase and α-glucosidase inhibitory activities of Oxalis pes-caprae extracts in alloxan-induced diabetic mice.
Topics: Alloxan; alpha-Amylases; alpha-Glucosidases; Animals; Antioxidants; Diabetes Mellitus, Experimental; | 2023 |
Therapeutic Potential of
Topics: Alloxan; Animals; Antioxidants; Apoptosis; Diabetes Mellitus, Experimental; Dilleniaceae; Glucose Tr | 2023 |
Phenolics Extracted from
Topics: Alloxan; Animals; bcl-2-Associated X Protein; Biomarkers; Blood Glucose; Caspase 3; Diabetes Mellitu | 2023 |
Effect of Caesalpinia bonduc Polyphenol Extract on Alloxan-Induced Diabetic Rats in Attenuating Hyperglycemia by Upregulating Insulin Secretion and Inhibiting JNK Signaling Pathway.
Topics: Alloxan; Animals; Caesalpinia; Diabetes Mellitus, Experimental; Disease Models, Animal; Herbal Medic | 2020 |
Berberis lycium Royle. extracts attenuate inflammation and modulates hyperglycemia in alloxan induced diabetic rats.
Topics: Alloxan; alpha-Amylases; Animals; Antioxidants; Berberis; Blood Glucose; Diabetes Mellitus, Experime | 2020 |
Efficacy of Caffeic Acid on Diabetes and Its Complications in the Mouse.
Topics: Alloxan; Animals; Antioxidants; Apoptosis; Atherosclerosis; Blood Glucose; Caffeic Acids; Diabetes C | 2021 |
Histopathological and biochemical assessments of Costus afer stem on alloxan-induced diabetic rats.
Topics: Alloxan; Animals; Biomarkers; Body Weight; Costus; Diabetes Mellitus, Experimental; Glyburide; Hyper | 2017 |
Insight into anti-diabetic effect of low dose of stevioside.
Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diterpe | 2017 |
Antihyperglycemic, antioxidant activities of tucumã oil (Astrocaryum vulgare) in alloxan-induced diabetic mice, and identification of fatty acid profile by gas chromatograph: New natural source to treat hyperglycemia.
Topics: Alloxan; Animals; Antioxidants; Body Weight; Chromatography, Gas; Diabetes Mellitus, Experimental; E | 2017 |
Brazilian
Topics: Alloxan; Animals; Blood Glucose; Brazil; Diabetes Mellitus, Experimental; Dyslipidemias; Glucose Tol | 2017 |
Amelioration of hyperglycaemia and modulation of antioxidant status by Alcea rosea seeds in alloxan-induced diabetic rats.
Topics: Alloxan; Animals; Antioxidants; Biomarkers; Diabetes Mellitus, Experimental; Dose-Response Relations | 2017 |
Anti-hyperglycemic potential of Lactobacillus spp. in alloxan-induced Wistar rats.
Topics: Alloxan; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Hyperglycemia; Hypogl | 2017 |
The hypoglycemic and antioxidant effects of polysaccharides from the petioles and pedicels of Euryale ferox Salisb. on alloxan-induced hyperglycemic mice.
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Female; Humans; Hype | 2017 |
Report - Antidiabetic effects of native date fruit Aseel (Phoenix dactylifera L.) in normal and hyperglycemic rats.
Topics: Alloxan; Animals; Biomarkers; Blood Glucose; Diabetes Mellitus, Experimental; Fruit; Glyburide; Hype | 2017 |
Anti-hyperglycaemic Effects of Rutin on Blood Glucose, Oxidative Stress Biomarkers and Lipid Peroxidation in Alloxan-induced Hyperglycaemic Wistar Rats.
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Hyperglycemia; Hypog | 2017 |
The hypoglycemic and antioxidant activities of garden cress (Lepidium sativum L.) seed on alloxan-induced diabetic male rats.
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Hyperglycemia; Hypog | 2019 |
Endogenous Reprogramming of Alpha Cells into Beta Cells, Induced by Viral Gene Therapy, Reverses Autoimmune Diabetes.
Topics: Alloxan; Animals; Blood Glucose; Cellular Reprogramming; Dependovirus; Diabetes Mellitus, Experiment | 2018 |
Effect of Moringa oleifera consumption on diabetic rats.
Topics: Alloxan; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Enterobacteriaceae; F | 2018 |
Therapeutic effect of vitamin B
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, T | 2018 |
Antidiabetic Potentials of Citrus aurantifolia Leaf Essential Oil.
Topics: Alloxan; Animals; Citrus; Gas Chromatography-Mass Spectrometry; Glucose; Glycogen; Hyperglycemia; Hy | 2019 |
Extended Duration of Hyperglycemia Result in Human-Like Corneal Nerve Lesions in Mice With Alloxan- and Streptozotocin-Induced Type 1 Diabetes.
Topics: Alloxan; Animals; Cornea; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Neuro | 2018 |
Antidiabetic role of a novel protein from garlic via NO in expression of Glut-4/insulin in liver of alloxan induced diabetic mice.
Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Garlic; Glucose; Glucose Transport | 2019 |
Chemical constituents of Cochlospermum regium (Schrank) Pilg. root and its antioxidant, antidiabetic, antiglycation, and anticholinesterase effects in Wistar rats.
Topics: Alloxan; Animals; Antioxidants; Bixaceae; Blood Glucose; Cholinesterase Inhibitors; Diabetes Mellitu | 2019 |
Responsivity of lateral septum-mPFC connections in alloxan-induced hyperglycemia.
Topics: Alloxan; Animals; Antidepressive Agents; Brain; Diabetes Mellitus, Experimental; Fear; Fluoxetine; H | 2019 |
Effect of vitamin E on alloxan-induced mouse diabetes.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Administration, Oral; Alloxan; alpha-Tocopherol; Animals; Antioxidants; | 2013 |
Dynamics of lipid peroxidation-antioxidant defense system during alloxan diabetes in rats.
Topics: Alloxan; alpha-Tocopherol; Animals; Antioxidants; Blood Glucose; Cholesterol; Diabetes Mellitus, Exp | 2013 |
Cerebroprotective effects of emoxipin, reamberin, and mexidol in alloxan diabetes.
Topics: Alloxan; Animals; Astrocytes; Cerebral Cortex; Diabetes Mellitus, Experimental; Diencephalon; Female | 2013 |
[Dynamics of initial manifestations of experimental diabetic encephalopathy].
Topics: Alloxan; Animals; Behavior, Animal; Brain Diseases, Metabolic; Brain Mapping; Diabetes Mellitus, Exp | 2013 |
Lavender (Lavandula stoechas L.) essential oils attenuate hyperglycemia and protect against oxidative stress in alloxan-induced diabetic rats.
Topics: Alloxan; Animals; Antioxidants; Biphenyl Compounds; Diabetes Mellitus, Experimental; Gas Chromatogra | 2013 |
The protective effect of vanadium against diabetic cataracts in diabetic rat model.
Topics: Alloxan; Animals; Cataract; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Hypergl | 2014 |
Therapeutic effects of stem cell on hyperglycemia, hyperlipidemia, and oxidative stress in alloxan-treated rats.
Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Female; Flow Cytometry; Glutathion | 2014 |
[Protective effect of 3-oxypyridine and succinic acid derivatives under conditions of acute alloxan-induced intoxication in mice].
Topics: Alloxan; Animals; Behavior, Animal; Female; Hyperglycemia; Male; Mice; Pyridines; Succinates | 2014 |
Subacute antidiabetic and in vivo antioxidant effects of methanolic extract of Bridelia micrantha (Hochst Baill) leaf on alloxan-induced hyperglycaemic rats.
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Dose-Respo | 2014 |
Identification of O-GlcNAc modification targets in mouse retinal pericytes: implication of p53 in pathogenesis of diabetic retinopathy.
Topics: Acetylglucosamine; Alloxan; Animals; Apoptosis; Diabetic Retinopathy; Disease Models, Animal; Endoth | 2014 |
Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice.
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Type 2; DNA Damage; Glucose Transp | 2014 |
Continuous electrical current and zinc sulphate administered by transdermal iontophoresis improves skin healing in diabetic rats induced by alloxan: morphological and ultrastructural analysis.
Topics: Administration, Cutaneous; Alloxan; Animals; Cell Proliferation; Collagen; Diabetes Mellitus, Experi | 2014 |
Study of Antiglycation, Hypoglycemic, and Nephroprotective Activities of the Green Dwarf Variety Coconut Water (Cocos nucifera L.) in Alloxan-Induced Diabetic Rats.
Topics: Acarbose; Alloxan; Animals; Antioxidants; Beverages; Caffeic Acids; Cocos; Diabetes Mellitus, Experi | 2015 |
[Role of functional state of neuronal mitochondria of cerebral cortex in mechanisms of nootropic activity of neuroprotectors in rats with alloxan hyperglycemia].
Topics: Alloxan; Amnesia; Animals; Avoidance Learning; Cerebral Cortex; Cognition; Cytidine Diphosphate Chol | 2015 |
Liraglutide improves pancreatic Beta cell mass and function in alloxan-induced diabetic mice.
Topics: Alloxan; Animals; Apoptosis; Blood Glucose; Cell Proliferation; Cell Size; Diabetes Mellitus, Experi | 2015 |
Cordycepin from Cordyceps militaris prevents hyperglycemia in alloxan-induced diabetic mice.
Topics: Alloxan; Animals; Animals, Outbred Strains; Blood Glucose; Cordyceps; Deoxyadenosines; Diabetes Comp | 2015 |
Relationship among Short and Long Term of Hypoinsulinemia-Hyperglycemia, Dermatophytosis, and Immunobiology of Mononuclear Phagocytes.
Topics: Alloxan; Animals; Bone Marrow; Cell Adhesion; Diabetes Mellitus; Humans; Hydrogen Peroxide; Hypergly | 2015 |
Protective effect of vitamin E against alloxan-induced mouse hyperglycemia.
Topics: Acatalasia; Alloxan; Animals; Apoptosis; Hyperglycemia; Insulin; Male; Mice; Pancreas; Vitamin E | 2016 |
Nanopharmaceutical approach using pelargonidin towards enhancement of efficacy for prevention of alloxan-induced DNA damage in L6 cells via activation of PARP and p53.
Topics: Alloxan; Animals; Anthocyanins; Cell Line; DNA Damage; Hyperglycemia; Nanoparticles; Oxidative Stres | 2016 |
Widespread blunting of hypothalamic and amygdala-septal activity and behavior in rats with long-term hyperglycemia.
Topics: Alloxan; Amygdala; Anhedonia; Animals; Anxiety; Chronic Disease; Dietary Sucrose; Disease Models, An | 2016 |
A combination of cytokines EGF and CNTF protects the functional beta cell mass in mice with short-term hyperglycaemia.
Topics: Alloxan; Animals; Basic Helix-Loop-Helix Transcription Factors; Blood Glucose; Ciliary Neurotrophic | 2016 |
Diosmin Modulates the NF-kB Signal Transduction Pathways and Downregulation of Various Oxidative Stress Markers in Alloxan-Induced Diabetic Nephropathy.
Topics: Alloxan; Animals; Cytokines; Diabetic Nephropathies; Diosmin; Down-Regulation; Hyperglycemia; Hypogl | 2016 |
Effects of hyperglycemia on bone metabolism and bone matrix in goldfish scales.
Topics: Alloxan; Animals; Blood Glucose; Bone and Bones; Electrophoresis, Polyacrylamide Gel; Goldfish; Hype | 2017 |
The effect of a plant extract enriched in stigmasterol and β-sitosterol on glycaemic status and glucose metabolism in alloxan-induced diabetic rats.
Topics: Alloxan; Animals; Biomarkers; Cell Line, Tumor; Diabetes Mellitus, Experimental; Dietary Supplements | 2016 |
Hyperglycemia, oxidative stress, liver damage and dysfunction in alloxan-induced diabetic rat are prevented by Spirulina supplementation.
Topics: Alloxan; Animals; Anthocyanins; Blood Glucose; Catalase; Cholesterol; Diabetes Mellitus, Experimenta | 2016 |
Effects of Cymodocea nodosa extract on metabolic disorders and oxidative stress in alloxan-diabetic rats.
Topics: Alloxan; alpha-Amylases; Animals; Antioxidants; Blood Glucose; Cholesterol; Diabetes Mellitus, Exper | 2017 |
O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells.
Topics: Acetylglucosamine; Alloxan; Animals; Apoptosis; Cell Line; Glucosamine; Glucose; Humans; Hyperglycem | 2008 |
A comparison of hypoglycemic activity of three species of basidiomycetes rich in vanadium.
Topics: Alloxan; Analysis of Variance; Animals; Basidiomycota; Blood Glucose; Body Weight; Coprinus; Epineph | 2009 |
Ocular refractive changes accompanying high blood sugar in alloxan-treated dogs.
Topics: Alloxan; Animals; Blood Glucose; Diagnostic Techniques, Ophthalmological; Dogs; Eye; Hyperglycemia; | 1948 |
Kidney alkaline phosphatase of rats following alloxan induced diabetes and acute hypo- and hyperglycemia.
Topics: Alkaline Phosphatase; Alloxan; Animals; Diabetes Mellitus, Experimental; Hyperglycemia; Rats | 1948 |
Mechanism of action of the stimulatory effect of apigenin-6-C-(2''-O-alpha-l-rhamnopyranosyl)-beta-L-fucopyranoside on 14C-glucose uptake.
Topics: Alloxan; Androstadienes; Animals; Biological Transport; Blood Glucose; Carbon Radioisotopes; Colchic | 2009 |
Comparison of hypoglycemic activity and toxicity of vanadium (IV) and vanadium (V) absorbed in fermented mushroom of Coprinus comatus.
Topics: Alloxan; Animals; Blood Glucose; Coprinus; Hyperglycemia; Mice; Mice, Obese; Sucrose; Vanadium | 2009 |
Expression and characterization of Momordica Chanrantia anti-hyperglycaemic peptide in Escherichia coli.
Topics: Alloxan; Animals; Blood Glucose; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experiment | 2010 |
STUDIES ON GLYCOGEN NEPHROSIS IN ALLOXAN-TREATED DIABETIC RATS.
Topics: Alloxan; Animals; Body Weight; Diabetes Mellitus; Diabetes Mellitus, Experimental; Glycogen; Hypergl | 1947 |
Sensitization to alloxan-induced diabetes and pancreatic cell apoptosis in acatalasemic mice.
Topics: Acatalasia; Alloxan; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Be | 2010 |
The effects of diabetes and/or polymicrobial sepsis on the status of antioxidant enzymes and pro-inflammatory cytokines on heart, liver, and lung of ovariectomized rats.
Topics: Alloxan; Animals; Antioxidants; Catalase; Cytokines; Diabetes Mellitus, Experimental; Disease Models | 2011 |
Inhibition of δ-aminolevulinate dehydratase is not closely related to the development of hyperglycemia in alloxan-induced diabetic mice.
Topics: Alloxan; Animals; Blood Glucose; Enzyme Activation; Enzyme Inhibitors; Hyperglycemia; Kidney; Lipid | 2011 |
In vivo acute effects of orally administered hydro-ethanol extract of Catha edulis on blood glucose levels in normal, glucose-fed hyperglycemic, and alloxan-induced diabetic rats.
Topics: Administration, Oral; Alloxan; Animals; Blood Glucose; Catha; Diabetes Mellitus, Experimental; Gluco | 2010 |
A method for consistent induction of chronic hyperglycemia with alloxan.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Humans; Hyperglycemia | 1945 |
Chemical characterization of various fractions of leaves of Cinnamomum tamala Linn toward their antioxidant, hypoglycemic, and anti-inflammatory property.
Topics: Alloxan; Animals; Anti-Inflammatory Agents; Antioxidants; Carrageenan; Cells, Cultured; Cinnamomum; | 2011 |
Effects of two oral antidiabetics, pioglitazone and repaglinide, on aconitase inactivation, inflammation and oxidative/nitrosative stress in tissues under alloxan-induced hyperglycemia.
Topics: Aconitate Hydratase; Administration, Oral; Alloxan; Animals; Blood Glucose; Body Weight; Carbamates; | 2011 |
Hypoglycaemic action of stevioside and а barley and brewer's yeast based preparation in the experimental model on mice.
Topics: Alloxan; Animals; Blood Glucose; Chromium; Diabetes Mellitus, Experimental; Disease Models, Animal; | 2011 |
Early hyperglycemia following alloxan administration in vivo is not associated with altered hepatic mitochondrial function: acceptable model for type 1 diabetes?
Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease | 2011 |
The influence of alloxan-induced diabetes on Müller cell contraction-promoting activities in vitreous.
Topics: Alloxan; Animals; Blood Glucose; Blotting, Western; Carbonic Anhydrase I; Carbonic Anhydrase II; Dia | 2011 |
Oral administration of levan polysaccharide reduces the alloxan-induced oxidative stress in rats.
Topics: Administration, Oral; Alloxan; Animals; Bacillus; Blood Glucose; Catalase; Diabetes Mellitus, Experi | 2011 |
Antihyperglycemic potentials of a threatened plant, Helonias dioica: antioxidative stress responses and the signaling cascade.
Topics: Alloxan; Animals; Caspase 3; Catalase; Cells, Cultured; Cyclooxygenase 2; Cytochromes c; DNA Damage; | 2012 |
Chronic intrarenal insulin replacement reverses diabetes mellitus-induced natriuresis and diuresis.
Topics: Alloxan; Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Disease Models, An | 2012 |
Vitis vinifera L. grape skin extract activates the insulin-signalling cascade and reduces hyperglycaemia in alloxan-induced diabetic mice.
Topics: Alloxan; Animals; Blood Glucose; Blotting, Western; Body Weight; Diabetes Mellitus, Experimental; Di | 2012 |
The control of hyperglycemia in alloxan treated diabetic mice through the stimulation of hepatic insulin synthesis due to the production of nitric oxide.
Topics: Administration, Cutaneous; Administration, Oral; Alloxan; Animals; Anti-Inflammatory Agents, Non-Ste | 2012 |
[Antihypoxic effect of 3-hydroxypyridine and succinic acid derivatives and their nootropic action in alloxan diabetes].
Topics: Alloxan; Animals; Conditioning, Classical; Diabetes Mellitus, Experimental; Diabetic Neuropathies; D | 2011 |
Insulin growth factor adjustment in preimplantation rabbit blastocysts and uterine tissues in response to maternal type 1 diabetes.
Topics: Alloxan; Animals; Blastocyst; Cell Differentiation; Diabetes Mellitus, Experimental; Diabetes Mellit | 2012 |
Effects of insulin-like growth factor I on alveolar bone remodeling in diabetic rats.
Topics: Alloxan; Alveolar Process; Animals; Blood Glucose; Bone Density; Bone Remodeling; Calcification, Phy | 2013 |
Hyperglycemia aggravates atrial interstitial fibrosis, ionic remodeling and vulnerability to atrial fibrillation in diabetic rabbits.
Topics: Alloxan; Animals; Atrial Fibrillation; Atrial Remodeling; Diabetes Mellitus, Experimental; Disease M | 2012 |
Protective effects of taurine against alloxan-induced diabetic cataracts and refraction changes in New Zealand White rabbits.
Topics: Alloxan; Animals; Blood Glucose; Body Weight; Cataract; Diabetes Mellitus, Experimental; Hyperglycem | 2012 |
L-Arginine ameliorates cardiac left ventricular oxidative stress by upregulating eNOS and Nrf2 target genes in alloxan-induced hyperglycemic rats.
Topics: Alloxan; Animals; Arginine; Caspase 3; Diabetes Mellitus, Experimental; Gene Expression Regulation; | 2012 |
Early pancreas transplant improves motor nerve conduction in alloxan-induced diabetic rats.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Progression; Glyca | 2012 |
In vitro and in vivo assessment of the antioxidant activity of melatonin and related indole derivatives.
Topics: Alloxan; Animals; Antioxidants; Carboxylic Acids; Female; Hyaluronic Acid; Hyperglycemia; In Vitro T | 2002 |
Antihyperglycaemic effect and acute toxicity of Securigera Securidaca L. seed extracts in mice.
Topics: Administration, Oral; Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Respons | 2002 |
Hypoglycemic activity of ginseng glycopeptide.
Topics: Alloxan; Animals; Blood Glucose; Glycogen; Glycopeptides; Hyperglycemia; Hypoglycemic Agents; Liver; | 2003 |
Lipid hydroperoxide induced corneal neovascularization in hyperglycemic rabbits.
Topics: Alloxan; Animals; Blood Glucose; Corneal Neovascularization; Endothelial Growth Factors; Glycated He | 2002 |
[Experimental study on the hypoglycemic effect of tangniaole capsule].
Topics: Alloxan; Animals; Blood Glucose; Capsules; Diabetes Mellitus, Experimental; Dioscorea; Drugs, Chines | 2002 |
Synthesis and pharmacological evaluation of new 1,2-dithiolane based antioxidants.
Topics: Alloxan; Animals; Antioxidants; Body Temperature; Drug Evaluation, Preclinical; Hyperglycemia; Lipid | 2003 |
Antihyperglycemic activity of Caralluma attenuata.
Topics: Administration, Oral; Alloxan; Animals; Apocynaceae; Blood Glucose; Diabetes Mellitus, Experimental; | 2003 |
In vitro and in vivo protective effect of Ganoderma lucidum polysaccharides on alloxan-induced pancreatic islets damage.
Topics: Alloxan; Animals; Cell Survival; Cells, Cultured; Diabetes Mellitus, Experimental; Dose-Response Rel | 2003 |
Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness.
Topics: Alloxan; Animals; Blood Gas Analysis; Blood Glucose; Body Weight; Burns; Critical Illness; Diabetes | 2003 |
Hyperglycemia-glycogenolytic factor in diabetic man and alloxan-diabetic animals.
Topics: Alloxan; Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Glucagon; Humans; Hyperglycemi | 1952 |
[Direct glycogenolytic effect of alloxan in the mechanism of initial hyperglycemia of alloxan poisoning].
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Glycogenolysis; Hyperglycemia | 1953 |
Studies on the mechanism of alloxan initial hyperglycemia. I. A role of pituitary and adrenal gland in connection with the effect of alloxan on the blood sugar.
Topics: Adrenal Glands; Alloxan; Blood Glucose; Hyperglycemia; Pituitary Gland | 1954 |
Studies on the mechanism of alloxan initial hyperglycemia. II. Role of the liver in connection with the effect of alloxan on the blood sugar.
Topics: Abdomen; Alloxan; Blood Glucose; Hyperglycemia; Liver; Portal System | 1954 |
Studies on the mechanism of primary alloxan hyperglycemia and hypoglycemia in rabbits.
Topics: Alloxan; Animals; Blood Glucose; Hyperglycemia; Hypoglycemia; Rabbits | 1955 |
Effect of alloxan on obese hyperglycaemic mice.
Topics: Alloxan; Animals; Hyperglycemia; Mice; Mice, Obese; Obesity | 1962 |
EXTREME SENSITIVITY OF OBESE HYPERGLYCEMIC MICE TO CAFFEINE AND COFFEE.
Topics: Alloxan; Animals; Blood Glucose; Caffeine; Coffee; Glucose Tolerance Test; Hyperglycemia; Insulin; M | 1964 |
[Inhibiting effect of adrenalectomy on alloxan hyperglycemia].
Topics: Adrenal Glands; Adrenalectomy; Alloxan; Animals; Diabetes Mellitus, Experimental; Hyperglycemia | 1954 |
[Effect of adrenal grafts in the anterior chamber of the eye on alloxan hyperglycemia in rat].
Topics: Adrenal Glands; Alloxan; Animals; Anterior Chamber; Diabetes Mellitus, Experimental; Hyperglycemia; | 1954 |
[Studies on physiopathology of hypothermia in homotherms; effect of deep hypothermia on alloxan hyperglycemia].
Topics: Alloxan; Animals; Body Temperature; Diabetes Mellitus, Experimental; Hyperglycemia; Hypothermia | 1954 |
The effect of amphenone and DDD on the early post-alloxanic hyperglycemia in rats.
Topics: Alloxan; Animals; Contraceptive Agents, Female; DDT; Dichlorodiphenyldichloroethane; Estradiol Conge | 1960 |
Hypoglycemic effect of Rehmannia glutinosa oligosaccharide in hyperglycemic and alloxan-induced diabetic rats and its mechanism.
Topics: Alloxan; Animals; Blood Glucose; Corticosterone; Diabetes Mellitus, Experimental; Female; Glucose-6- | 2004 |
[Mechanism of the transitory hyperglycemia determined by alloxan].
Topics: Alloxan; Blood Glucose; Hyperglycemia | 1950 |
Third ventricular alloxan reversibly impairs glucose counterregulatory responses.
Topics: Alloxan; Animals; Blood Glucose; Eating; Enzyme Inhibitors; Fourth Ventricle; Glucokinase; Glucose; | 2004 |
Antihyperglycemic activity of Eclipta alba leaf on alloxan-induced diabetic rats.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Eclipta; Hyperglycemia; Hypoglycemic Agents; Male | 2003 |
Prevailing hyperglycemia is critical in the regulation of glucose metabolism during exercise in poorly controlled alloxan-diabetic dogs.
Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dogs; Drug Combinations; Exercise | 2005 |
Effects of pioglitazone on hyperglycemia-induced alterations in antioxidative system in tissues of alloxan-treated diabetic animals.
Topics: Alloxan; Animals; Antioxidants; Diabetes Mellitus, Experimental; Glutathione; Glutathione Peroxidase | 2005 |
Involvement of Ca2+/calmodulin-dependent protein kinase II in the modulation of indolamines in diabetic and hyperglycemic rats.
Topics: Acidosis; Alloxan; Ammonium Chloride; Analysis of Variance; Animals; Bicarbonates; Blood Glucose; Bl | 2005 |
Age-related differences in the degree of lipid peroxidation and state of antioxidant protection under the influence of alloxan.
Topics: Aging; Alloxan; Animals; Antioxidants; Diabetes Mellitus, Experimental; Hyperglycemia; Hyperlipidemi | 2005 |
Hypoglycemic effect of ethanolic extract of Musa sapientum on alloxan induced diabetes mellitus in rats and its relation with antioxidant potential.
Topics: Administration, Oral; Alloxan; Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental | 2005 |
Hypoglycemic and antiperglycemic effects of Semecarpus anacardium linn in normal and alloxan-induced diabetic rats.
Topics: Administration, Oral; Alloxan; Analysis of Variance; Animals; Antioxidants; Blood Glucose; Diabetes | 2005 |
Hypoglycemic activity of fermented mushroom of Coprinus comatus rich in vanadium.
Topics: Alloxan; Animals; Blood Glucose; Coprinus; Epinephrine; Female; Fermentation; Glucose Tolerance Test | 2006 |
Gliclazide: pharmacokinetic-pharmacodynamic relationships in rats.
Topics: Administration, Oral; Alloxan; Animals; Area Under Curve; Blood Glucose; Chromatography, High Pressu | 2007 |
Effect of hyperglycemia on the efficacy of morphine analgesia in rats.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Female; Hyperglycemia; Morphine; Pain; Pain Measu | 2006 |
Hyperglycemia and glucosuria following thyroid administration in alloxan treated rats.
Topics: Alloxan; Animals; Blood Glucose; Carbohydrates; Glycosuria; Hyperglycemia; Rats; Thyroid Gland; Urin | 1949 |
The effect of altered carbohydrate metabolism in pertussis-sensitized mice on anaphylaxis.
Topics: Alloxan; Anaphylaxis; Animals; Blood Glucose; Body Weight; Diazoxide; Eating; Epinephrine; Female; G | 1967 |
On the hyperglycaemic effect of DOPA and dopamine.
Topics: Alloxan; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Dihydroxyphenylalanine; Dopamine; Hy | 1967 |
Complications of pregnancy and fetal development.
Topics: Alloxan; Animals; Congenital Abnormalities; Cricetinae; Cricetulus; Diabetes Mellitus, Experimental; | 1982 |
Survival of intrasplenically implanted islets in mice with experimental insulitis and hyperglycemia.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Female; Graft Survival | 1982 |
Alloxan-induced hyperglycemia increases progestin and androgen accumulation by isolated rabbit follicles in vitro.
Topics: Alloxan; Androgens; Animals; Female; Hyperglycemia; Luteinizing Hormone; Ovarian Follicle; Progestin | 1984 |
Effects of acetazolamide on insulin release, serum glucose and insulin, glucose tolerance, and alloxan sensitivity of mice.
Topics: Acetazolamide; Alloxan; Animals; Blood Glucose; Carbonic Anhydrases; Glucose Tolerance Test; Hypergl | 1980 |
Effect of peripheral versus portal venous administration of insulin on postprandial hyperglycemia and glucose turnover in alloxan-diabetic dogs.
Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dogs; Eating; Hyperglycemia; Injec | 1981 |
Importance of glucagon in mediating epinephrine-induced hyperglycemia in alloxan-diabetic dogs.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Dogs; Epinephrine; Glucagon; Glucose; Hyperglycem | 1981 |
Comparison of systemic and uterine effects of relaxin and insulin in alloxan-treated, hyperglycemic rats.
Topics: Alloxan; Animals; Castration; Diabetes Mellitus, Experimental; Estradiol; Female; Hyperglycemia; Ins | 1982 |
Effect of 'catalin' an anticataract agent on alloxan induced hyperglycaemia and diabetic cataract in rats.
Topics: Alloxan; Animals; Cataract; Diabetes Mellitus, Experimental; Female; Hyperglycemia; Male; Oxazines; | 1980 |
Effect of hyperglycemia on the enzyme activities of lenticular tissue of rats.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Hyperglycemia; Lens, Crystalline; Rats | 1980 |
Long-term effects of alloxan in mice.
Topics: Alloxan; Animals; Blood Glucose; Carbachol; Diabetes Mellitus, Experimental; Dose-Response Relations | 1995 |
Impairment of glucose-induced insulin secretion in human pancreatic islets transplanted to diabetic nude mice.
Topics: Adolescent; Adult; Alloxan; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glu | 1995 |
Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats.
Topics: Alloxan; Animals; Basement Membrane; Capillaries; Diabetes Mellitus, Experimental; Diabetic Retinopa | 1994 |
Pancreatic lipid peroxidation in alloxan-induced diabetes mellitus.
Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glutathione; Hyperglycemia; Lipid | 1994 |
A new diabetes model induced by neonatal alloxan treatment in rats.
Topics: Acetylglucosaminidase; Aging; Alloxan; Animals; Animals, Newborn; Blood Glucose; Body Weight; Diabet | 1993 |
Control of hyperglycaemia in diabetic rabbits by a combination of implants.
Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Drug Implants; Eating; Hyperglycem | 1993 |
Plasma atrial natriuretic peptide levels in rabbits with alloxan monohydrate-induced diabetes mellitus.
Topics: Alloxan; Animals; Atrial Natriuretic Factor; Blood Glucose; Diabetes Mellitus, Experimental; Electro | 1995 |
Inhibition of alloxan-induced hyperglycaemia in mice by the pyridoindole stobadine.
Topics: Alloxan; Animals; Antioxidants; Blood Glucose; Carbolines; Disease Models, Animal; Dose-Response Rel | 1995 |
Oxygen consumption and ATPase activity in the corneal epithelium of rabbits with alloxan induced hyperglycemia.
Topics: Adenosine Triphosphatases; Alloxan; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experime | 1998 |
Evidence for direct action of alloxan to induce insulin resistance at the cellular level.
Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dogs; Glucose Clamp Technique; Glu | 1998 |
Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia.
Topics: Alloxan; Animals; Arginine; Blood Glucose; Body Weight; Carotid Arteries; Cyclic GMP; Endothelium, V | 1999 |
Effect of some antidepressants on glycaemia and insulin levels of normoglycaemic and alloxan-induced hyperglycaemic mice.
Topics: Alloxan; Animals; Antidepressive Agents; Blood Glucose; Female; Fluoxetine; Hyperglycemia; Insulin; | 1999 |
Enhanced alloxan-induced beta-cell damage and delayed recovery from hyperglycemia in mice lacking extracellular-superoxide dismutase.
Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Female; Free Radicals; Hyperglycem | 1999 |
Reduced nociceptive responses in mice with alloxan induced hyperglycemia after garlic (Allium sativum Linn.) treatment.
Topics: Alloxan; Animals; Garlic; Hyperglycemia; Male; Mice; Pain; Plant Extracts; Plants, Medicinal | 1999 |
Alpha-phenyl-tert-butylnitrone (PBN) inhibits NFkappaB activation offering protection against chemically induced diabetes.
Topics: Alloxan; Animals; Cyclic N-Oxides; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Free | 2000 |
Protective effect of the antioxidant 6-ethoxy-2,2-pentamethylen-1,2-dihydroquinoline (S 33113) in models of cerebral neurodegeneration.
Topics: Alloxan; Animals; Antioxidants; Body Temperature; Brain Ischemia; Cell Survival; Cerebral Cortex; Co | 2001 |
Hypoglycemic and antihyperglycemic activity of Syzygium alternifolium (Wt.) Walp. seed extracts in normal and diabetic rats.
Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; | 2001 |
Urethane-induced hyperglycemia.
Topics: Alloxan; Animals; Blood Glucose; Epinephrine; Fasting; Hyperglycemia; Insulin; Male; Rats; Urethane | 2000 |
Administration of NF-kappaB decoy inhibits pancreatic activation of NF-kappaB and prevents diabetogenesis by alloxan in mice.
Topics: Alloxan; Animals; Apoptosis; Diabetes Mellitus, Experimental; Disease Models, Animal; Hyperglycemia; | 2001 |
Effect of aluminum on the blood-brain barrier permeability in acute and chronically hyperglycemic rats.
Topics: Acute Disease; Alloxan; Aluminum; Animals; Blood-Brain Barrier; Chronic Disease; Coloring Agents; Ev | 2001 |
The protective effect of Amomum xanthoides extract against alloxan-induced diabetes through the suppression of NFkappaB activation.
Topics: Alloxan; Animals; Blood Glucose; Cell Nucleus; Diabetes Mellitus, Experimental; Dose-Response Relati | 2001 |
[Experimental grafts of pancreatic islands of Langerhans in the rat].
Topics: Alloxan; Animals; Body Weight; Glycosuria; Hyperglycemia; Islets of Langerhans; Islets of Langerhans | 1978 |
Increased sensitivity of in vivo platelet aggregation in rabbits after alloxan or streptozotocin.
Topics: Adenosine Diphosphate; Alloxan; Animals; Blood Glucose; Cerebral Cortex; Diabetes Mellitus, Experime | 1976 |
Antagonism of cadmium and alloxan-induced hyperglycemia in rats by Trigonella foenum graecum.
Topics: Acetone; Alloxan; Animals; Cadmium; Diabetes Mellitus, Experimental; Hyperglycemia; Hypoglycemic Age | 1977 |
Distribtuion of gamma-aminobutyric acid (GABA) in the rat hypothalamus: functional correlates of GABA wtih activities of appetite controlling mechanisms.
Topics: Alloxan; Aminobutyrates; Animals; Appetite; gamma-Aminobutyric Acid; Hyperglycemia; Hypothalamus; Hy | 1975 |
Cataracts in beagle dogs given diazoxide.
Topics: Administration, Oral; Alloxan; Animals; Blood Glucose; Cataract; Diazoxide; Dogs; Dose-Response Rela | 1975 |
Inhibition of alloxan-induced hyperglycaemia by compounds of similar molecular structure.
Topics: Allantoin; Alloxan; Animals; Barbiturates; Blood Glucose; Caffeine; Ethosuximide; Hyperglycemia; Ino | 1992 |
Intra-islet insulin permits glucose to directly suppress pancreatic A cell function.
Topics: Alloxan; Animals; Arginine; Dogs; Glucagon; Glucose; Hyperglycemia; Insulin; Insulin Secretion; Isle | 1991 |
Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy.
Topics: Alloxan; Animals; Capillaries; Diabetic Retinopathy; Granulocytes; Hyperglycemia; Leukocytes; Macrop | 1991 |
Effect of intracerebroventricularly administered insulin on brain monoamines and acetylcholine in euglycaemic and alloxan-induced hyperglycaemic rats.
Topics: Acetylcholine; Alloxan; Animals; Biogenic Monoamines; Hyperglycemia; Injections, Intraventricular; I | 1991 |
Increased incidence of neuroleptic-induced perioral movements in the rat by hyperglycemia.
Topics: Alloxan; Animals; Blood Glucose; Dyskinesia, Drug-Induced; Female; Haloperidol; Hyperglycemia; Rats; | 1990 |
Modulation of insulin receptors and catecholamines in rat brain in hyperglycemia and hyperinsulinemia.
Topics: Alloxan; Animals; Brain; Catecholamines; Cell Membrane; Choroid Plexus; Chromatography, High Pressur | 1990 |
Definition of streptozocin toxicity for primary lymphoidal tissues.
Topics: Alloxan; Animals; Bone Marrow; Bone Marrow Cells; Cell Cycle; DNA; Hyperglycemia; Leukocyte Count; L | 1986 |
Nickel chloride protection against alloxan- and streptozotocin-induced diabetes.
Topics: Alloxan; Animals; Blood Glucose; Ceruloplasmin; Diabetes Mellitus, Experimental; Hyperglycemia; Insu | 1988 |
Mechanism of the protective activity of ICRF-187 against alloxan-induced diabetes in mice.
Topics: Alloxan; Animals; Blood Glucose; Chelating Agents; Cimetidine; Diabetes Mellitus, Experimental; Dime | 1986 |
Alloxan-induced diabetes mellitus in pregnant sheep and chronic fetal catheterization.
Topics: Alloxan; Animals; Birth Weight; Blood Gas Analysis; Blood Glucose; Catheterization; Diabetes Mellitu | 1988 |
Variations of susceptibility to alloxan induced diabetes in the rabbit.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Disease Susceptibility; D | 1987 |
Alloxan-induced hyperglycemia in rabbits and the response of platelets to aggregating agents in vitro and to exposed subendothelium in vivo.
Topics: Adenosine Diphosphate; Alloxan; Animals; Arteries; Blood Platelets; Cell Adhesion; Collagen; Diabete | 1987 |
The influence of estrogen on the hyperglycemic action of alloxan in female rats.
Topics: Alloxan; Animals; Blood Glucose; Estrogens; Estrus; Female; Glucose Tolerance Test; Hyperglycemia; O | 1986 |
Changes in the rats preference for saccharin and sodium chloride solutions following injection of alloxan monohydrate.
Topics: Age Factors; Alloxan; Animals; Appetite; Avoidance Learning; Blood Glucose; Body Weight; Chronic Dis | 1974 |
[Proceedings: Hyperglycemia in the early phase of alloxan administration and sympathetic nerve interruption].
Topics: Alloxan; Hyperglycemia; Sympathetic Nervous System | 1974 |
Acute effects of alloxan on the metabolism and insulin secretion of the pancreatic B-cell.
Topics: Alloxan; Anaerobiosis; Animals; Carbon Radioisotopes; Citrates; Female; Genotype; Glucose; Glycolysi | 1973 |
The relationship of hyperglycemia to periodontal disease.
Topics: Alloxan; Animals; Haplorhini; Hyperglycemia; Macaca; Periodontal Diseases; Pituitary Hormones, Anter | 1973 |
Studies on the protective effect of diphenylhydantoin against alloxan diabetes in mice.
Topics: Alloxan; Animals; Binding, Competitive; Blood Glucose; Diabetes Mellitus, Experimental; Glucose; Hyp | 1973 |
Sulfhydryl inhibitors and pancreatic islet tissue.
Topics: Alloxan; Animals; Arsenicals; Cadmium; Chlorides; Cobalt; Diabetes Mellitus, Experimental; Fishes; H | 1969 |
Effects of alloxan upon goldfish (Carassius auratus L.).
Topics: Adrenal Glands; Alloxan; Animals; Blood Glucose; Cyprinidae; Diabetes Mellitus, Experimental; Epinep | 1970 |
Alloxan effects on blood glucose level and pancreatic islet tissue in Lampetra fluviatilis.
Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Female; Fishes; Hyperglycemia; Isl | 1970 |
[Inhibition of diabetogenic effect of alloxan by intraperitoneal administration of glucose in mice].
Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucose; Hyperglycemia; Injections | 1970 |
Infectivity of Trichinella spiralis (nematoda) muscle larva in normal- vs. alloxan-treated rats.
Topics: Alloxan; Animals; Diaphragm; Glycogen; Hyperglycemia; Larva; Male; Muscles; Rats; Trichinella; Trich | 1972 |
Effect of ecdysterone on hyperglycemia in experimental animals.
Topics: Alloxan; Animals; Carbon Isotopes; Cholestanes; Diabetes Mellitus, Experimental; Drug Antagonism; Gl | 1971 |
The effect of agents used in the treatment of bronchial asthma on carbohydrate metabolism and histamine sensitivity after beta-adrenergic blockade.
Topics: Adenine Nucleotides; Adrenal Cortex Hormones; Adrenalectomy; Alloxan; Aminophylline; Animals; Antige | 1970 |
Ultrastructural pancreatic beta-cell changes in rabbits after small and large doses of alloxan.
Topics: Alloxan; Animals; Blood Glucose; Cortisone; Diabetes Mellitus, Experimental; Hyperglycemia; In Vitro | 1967 |
[Enzyme activity of 3 beta-ol-steroid dehydrogenase in the adrenal cortex: histochemical studies following alloxan treatment].
Topics: Adrenal Glands; Alloxan; Animals; Diabetes Mellitus, Experimental; Guinea Pigs; Histocytochemistry; | 1969 |
Partial reversal of the in vivo antimalarial activity of DDS against Plasmodium berghei by induced hyperglycemia.
Topics: Administration, Oral; Alloxan; Animals; Antimalarials; Blood Glucose; Dapsone; Erythrocytes; Glucose | 1971 |
Liver insulinase activity in insulin deficient rats.
Topics: Alloxan; Animals; Blood Glucose; Body Weight; Endopeptidases; Enzyme Induction; Fasting; Hyperglycem | 1968 |
[Inhivition of inflammatory reactions by hyperglycemia].
Topics: Alloxan; Animals; Blood Glucose; Bradykinin; Dextrans; Glucose; Guinea Pigs; Hexoses; Histamine; Hyp | 1968 |